ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001435.1|Ikarugamycin_1 # 2 # 196 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.677	BGC0001435.1|Ikarugamycin_1 	2	196	+	Loose	400	24.2534	tetB(P)	31.71	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATCATGAACCCGTCGACGGACCTGAGCCACCTCGTGTGGCGCTTCAGCAGTTACAGCGGAGGAGAGGGCGAGTGCGTCGAGGTCGCCGATGACATACCCGGGGTCATACCCGTGCGGGACAGCAAGCGGCCCGCCGGGCCCGTGCTGGTGTTCCGGCACGAGGCGTGGCGGGCCTTCGTCGGCACCTTGAGGTGA	IMNPSTDLSHLVWRFSSYSGGEGECVEVADDIPGVIPVRDSKRPAGPVLVFRHEAWRAFVGTLR	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	9.82	gnl|BL_ORD_ID|737|hsp_num:0	804			1662	1785	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001435.1|Ikarugamycin_2 # 201 # 1073 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=CCCCC;rbs_spacer=9bp;gc_cont=0.730	BGC0001435.1|Ikarugamycin_2 	201	1073	-	Loose	500	25.409	OXA-22	28.7	3001417	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAGCCGCCCCGAGCGGTGGCGGCCGGGGGCGGCCGGTGTCACGCTGGCAGATGAGGCTGACGTGACAAGGGAGGACTCCGTGCTGACCACCGACTTCGTCCCCGGCTCCCCCTGCTGGCTCGACCTCGGCGCCCCGGACCCGGAGACGACCGCCGCCTTCTACGGCGCGGTCCTGGGCTGGACCTTCCGGCCCATGGGTCCGGAGGGCTCGGGGTACGGGGTCGTGCAGAGCGAGGGCCGCACGGTGGCCGGCCTGGGCCGCCTCACGGAGGAGGGCGCCCGCTCGGCGTGGATGCTCTACTTCGCCACCACCGACGCGGACGCCACCGCCGACGCCGTGACGAACGCGGGCGGCACCGTCCGGGTCGTCCCCACCGGCATGGACGACGAACACCGCATGGCCCAGTTCACCGATCCCCAGGGCGGCCGGTTCGCGGTCTTCGAACCCCGCGACGACCGGGGCGTGGAGGCGGTGGACGTCCCCGGCTCCCTGTCCTGGACCGAGCTGTACACCCCGGACGGCGCGGCGGCGAAGACCTTCTACACGGCGGTCTTCGGCTGGCAGTACTCCGAGATGCCCCTGCCGGGCGACAGTGGCACGTACTCCCTGATCACCCCGGCCACGGCGGACGAGAGCCGCATGCAGGGCGGGCTGATGCAACTTCCCCCCGACGCCCTGACCCTGACGAACGGCGCGGCGTACTGGCACCCTGTCTTCACCACGACGGACTGCGACGCGGCCACGGCCACGGTCACCCGGAACGCGGGCACGGTGCAGATGGGCCCCGAAACAGCGGAAGGCGTCGGCCGCCTGTCGGTCTGCGCCGACCCCAACGGCGCGGACTTCGTCCTGCTGACCCCGGAGACCTGA	MSRPERWRPGAAGVTLADEADVTREDSVLTTDFVPGSPCWLDLGAPDPETTAAFYGAVLGWTFRPMGPEGSGYGVVQSEGRTVAGLGRLTEEGARSAWMLYFATTDADATADAVTNAGGTVRVVPTGMDDEHRMAQFTDPQGGRFAVFEPRDDRGVEAVDVPGSLSWTELYTPDGAAAKTFYTAVFGWQYSEMPLPGDSGTYSLITPATADESRMQGGLMQLPPDALTLTNGAAYWHPVFTTTDCDAATATVTRNAGTVQMGPETAEGVGRLSVCADPNGADFVLLTPET	MKRRHAAIGALLAALATFAHAEHPICTIVADAATGKAVLHEGKCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGLMRRIVNRQLPVSAHTYEMLDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALFARLSEVLAFAGH	105.84	gnl|BL_ORD_ID|639|hsp_num:0	693			201	534	cloxacillin; oxacillin; cefalotin
BGC0001435.1|Ikarugamycin_3 # 1105 # 1860 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=11bp;gc_cont=0.693	BGC0001435.1|Ikarugamycin_3 	1105	1860	-	Loose	670	26.1794	Escherichia coli acrA	48.0	3004043	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGACTCAACAAGCCCGCGACCGCCGTCGCGGCGGCCCTGACCCTGACCGTGACGCTCGCCCTGACCGGCTGCTCGGCGGAGCGGATATCGCCCGAGAGCGTGCGCGACAAGGCCGACGAGAAGTCCGGCGGCGCGTTCGGCTCGGTGGACTGCCGCGAGGCCAAGTGCGTCGCCCTCACCTTCGACGCCGGCCCGGGCCCGTACACGGCCGAACTGCTGGACATCCTGGCCGAGGAAGAGGTCCCCGCGACGCTCTTCCTGCTCGGCAAGAAGCACATCGACACCTACCCCGAACTCGTGGTGCGCTCGGCCGAGGAAGGGCACGAGCTGGCCAACCACACCTGGACCCACCCCCGACTCACCGAGGTGGACCGGGACGAGGTGCGCGACCAGCTGCTGCGCACCAACGAGGCCATCGAGGAACTCACCGGGCAGACCCCGACGCTCATGCGCCCGCCGCAGGGCCGCACCGACGACACGGTCGCCGAGGTCTGCGAGGAACTGGGCCTGGCGCAGGTCCTGTGGTCCGTCACGGCCAAGGACTACTCGACCAACGACTCGGACCTGATCACCGAACGCGTCCTGGACCAGGTCGACCGCGACGGCATCATCCTGCTGCACGACATCTACGAGGGCACCGTCCCCGCCGTCCCCGGCATCATCGAGGCACTGAAGGCCGACGGATACACCTTCGTCACCGTCTCCCAGCTGATGGCGCCCGGCGTACCCGAACCGGGCAAGGTCTACCGCTGA	MRLNKPATAVAAALTLTVTLALTGCSAERISPESVRDKADEKSGGAFGSVDCREAKCVALTFDAGPGPYTAELLDILAEEEVPATLFLLGKKHIDTYPELVVRSAEEGHELANHTWTHPRLTEVDRDEVRDQLLRTNEAIEELTGQTPTLMRPPQGRTDDTVAEVCEELGLAQVLWSVTAKDYSTNDSDLITERVLDQVDRDGIILLHDIYEGTVPAVPGIIEALKADGYTFVTVSQLMAPGVPEPGKVYR	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	63.22	gnl|BL_ORD_ID|2321|hsp_num:0	2661			0	75	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001435.1|Ikarugamycin_4 # 2023 # 2394 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=12bp;gc_cont=0.782	BGC0001435.1|Ikarugamycin_4 	2023	2394	+	Loose	675	23.0978	emrA	34.38	3000027	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGGGCGTGAACCGGGTCCGTGGCGCGCTGCTGATCCTGGCGGTACTCGCCGGGGTGTTCGCCATGCACGCGCTCGCGCCGGGGGTCGTCATCTCCCCCGCGCATCACACGGAGGCCGCCGCGCCCGCGCACGACGCCGGTGGCGCGGCGCATCTCGACCACGCGGACCCGGACTGTGTGGCGGGTGGGGTCGGCGGGGCGCCGGCCCCGGTCGGTGCCGGGGCGGGGGTGACCAGTGGGGTCACGGTGCCGCCGGTCGTCGCCGCGCGGGAGCTCGCCGGGCCCGCCCCGCCCTGGGGGCAGCCCCGGCCGGAGGCTGGGGGCGGCGCGCCGCCTTCGCTGAGTTCTCTGCAGTCGCTGCGTATATAG	MAGVNRVRGALLILAVLAGVFAMHALAPGVVISPAHHTEAAAPAHDAGGAAHLDHADPDCVAGGVGGAPAPVGAGAGVTSGVTVPPVVAARELAGPAPPWGQPRPEAGGGAPPSLSSLQSLRI	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	31.54	gnl|BL_ORD_ID|1610|hsp_num:0	1757			651	747	nalidixic acid
BGC0001435.1|Ikarugamycin_5 # 2455 # 3036 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0001435.1|Ikarugamycin_5 	2455	3036	+	Loose	550	24.2534	OXA-275	24.53	3001731	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCTCGTACCGTTTCGCGGCGCGGGCGCTCAGCGCCGCCGCCGTCACCTCCGCCTTGCTGTTCACCGCCGGCTGCGGGAGCGATTCCGATGAGCCGGGCGGACATTCCCAGCACGGCGGCGCACCGGTTTCCGACGCCTTCAACGCGGCGGATCTCGCCTTCGTCCAGGGCATGATCCCGCACCACGAGCAGGCCATCGAGATGTCCGAACTCGCGGCCGGGCGCGCCGGATCGGACGCGGTGCGGGATCTGGCCGCCGTCATCGAGCAGGCCCAGGGGCCGGAGATCGACACACTCCGGTCATGGCTCTCGGACTGGGACGCCGAGCCGGCGGACCACGGCGGGCACGACATGACCGGCATGATGTCGGACGAGGACATGGCGGAGCTGGAAGGCTCCTCCGGCGCGGAATTCGACGCCGCTTTCCTGCGCCTGATGATCGCGCACCACGAGGGCGCGGTCGAGATGGCGCGGGAGCTGGAGCGGCAGGGGTCCTTCGCGCCCGCTCTGGAGATGGCGCAGGACATCATCTCCTCCCAGTCCGCTGAAATCGATCAAATGACCGAACTTCTGAACTGA	MTSYRFAARALSAAAVTSALLFTAGCGSDSDEPGGHSQHGGAPVSDAFNAADLAFVQGMIPHHEQAIEMSELAAGRAGSDAVRDLAAVIEQAQGPEIDTLRSWLSDWDAEPADHGGHDMTGMMSDEDMAELEGSSGAEFDAAFLRLMIAHHEGAVEMARELERQGSFAPALEMAQDIISSQSAEIDQMTELLN	MSNYRFKSKIKSSVLIILSSVAFSGCVSNANLHDPASSQRTSEIPLLFNYAQTQAVFVTYDGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKATNTEVFKWNGEKRSFPAWEKDMTLAQAMQASAVPVYQELARRIGLDLMSKEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQEAKFAFQLANKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR	68.68	gnl|BL_ORD_ID|2561|hsp_num:0	3441			0	153	cloxacillin; oxacillin; cefalotin
BGC0001435.1|Ikarugamycin_6 # 3411 # 12785 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0001435.1|Ikarugamycin_6 	3411	12785	+	Loose	1000	107.457	almE	29.7	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGATTCCATGCATCACCCTGCCCCCGTCCCCGTACCCGAAGTCCCCACGCCCGTCCCGTCCCAGGACGACGCGTTCGCCATCGTCGGCATCGGCTGCCGCCTGCCCGGCGGCGCCAGCGACTACCGGACCTTCTGGCGCAACCTCCTCGACGGCAAGGACTGCATCACCGACACCCCCGCCGACCGCTACGACACCCGCACCCTGGGCAGCGGCGACAAGGCCAAGCCCGGCCGGCTGGTCGGCGGACGCGGTGGATACATCGACGGCTTCGACGAGTTCGACCCCGCCTTCTTCGGCATCAGCCCGCGCGAGGCCGAGCACATGGACCCCCAGCAGCGGAAGCTCCTGGAGGTCGCCTGGGAGGCGCTGGAGGACGGCGGCCTCAAGCCCGCCGAGCTGGCCGGCACCGATGTCGGGGTGTACGTCGGGGCGTTCACCCTCGACTACAAGATCCTGCAGTTCGCCGACCTCGGCTTCGAGACCCTGGCCGCGCACACCGCCACCGGCACCATGATGACGATGGTGTCCAACCGGATCTCGTACTGCTTCGACTTCCGCGGCCCCTCGGTCTCCGTCGACACCGCGTGCAGCGGCTCCCTGGTCGCCGTCCACCTGGCCTGCCAGAGCCTGCGCCGCGGCGAGACCTCCGTCGCCCTGGCCGGCGGCACCCTGCTGCACATGGCGCCGCAGTACACCATCGCCGAGACCAAGGGCGGGTTCCTCTCCCCCGACGGCCGCTCCCGCGCCCTGGACGCCGCCGCCAACGGCTACGTGCGCGCCGAGGGCGTCGGCATGGTCGCCATCAAGCGCCTCGCGGACGCGCAGCGCGACGGCGACCCCATCCACGCCGTCATCATCGGCAGCGGCGTCAACCAGGACGGCCGCACCAACGGCATCACCGTGCCCAACCCCGACGCCCAGGTCGCCCTGATCGAGCGGGTCTGCGCCGGCGCCGGCGTCACCCCCGGCAGCCTGCAGTACGTCGAGGCACACGGCACCTCCACCCCCGTCGGCGACCCGCTGGAGGCCAACGCCCTCGGCCGCGCGCTGTCCATCGGCCGCGAGCCGGGCGCCCGGACGTACGTCGGTTCGGTGAAGACCAACATCGGGCACACCGAGTCGGCCGCCGGCATCGCCGGGCTGATCAAGACGGTGCTCAGCCTCAAGCACAAGATCATCCCGCCGCACATCAACCTGGAGAAGCTCAACCCGCAGATCGACGAGGCGTCCCTGCCGTACGAGATCCCCCGCGAGCCCACCCCCTGGCCCGAGCACAGCGGGCCGGCCCGGGCCGGCGTCAACTCCTTCGGCTTCGGCGGGACCAACGCCCACGTCCTGCTCCAGGAGGCACCGCCCACCGCCGAGGAGCCCGCGCCACCGGCCACCGACGGGTACTCCGTGCTGCCGCTCAGCGCCCGCGACCCCGAAGCCTTTCCCGCCATCGCCGCGGGCCTGCGCGAACGACTCGCCGAGGGCCTGCCGGTGGGCGACGCCGCCTACACCCTCGCCCACCGGCGGCAGCATCTGGAGCAGCGGCTGTCCGTCGTGTACGACTCCCCCGAGGCCCTCGACGAGGTCCTCGGCGCCGTCGCCCGCGGCGAGAGCCATCCGCGTGCCGTCGCCGGCACCCAGCGCGAGGGCCTGGACCGGCGGCTGGTGTGGGTGTTCACCGGCATGGGCCCGCAGTGGTGGGCCATGGGCCGCCAGCTGTACGCGAGCGAGCCCGTCTACCGCGAGGTCATCGACCGCTGCGACCAGGAGATCGCCGCGCTCACCGGCTGGTCCCTCACCCAGGAGCTGAACGCCGACGAGGCCGACTCCCGGATGAGCGAGACCTGGCTCGCCCAGCCCGCCAACTTCGCCGTGCAGATCGCCCTGGCCGCCCTGTGGCGCAGCAAGGGCGTCCAGCCGGACGCCGTGACCGGGCACAGCACCGGTGAGGTCGCCGCGTTCTACGAGGCCGGGGTGTACACGCTCCCCGAGGCCGTGAAGATCGTGGTGCACCGCAGCCGGCTCCAGCAGAAGCTCATCGGCACCGGCTCCATGCTCGCCGTCAGCCTCACCGAGGCGGAGGCCGCCCGCCGGGTGCGCCCGCACGGCGACCGGGTCTCCATCGCCGCCGTCAACAGCCCCACCTCCATCACCCTGGCCGGGGACACCGAGGCGCTGGAGGTGATCGCCGCCGAGCTGGGCGCGGAGGACATCTTCGCCCGCTTCCTGGAGGTCGGCGTCCCGTACCACAGCCCCCGCATGGAGCTGATCAAGGACGAGCTGCTGACCTCGCTCGCCGATCTCAAGCCGCAGCAGGCGAAGTTGCCGCTGTATCTCACCGCGCTGCCGGGCACCGTCGCGCAGGGCACGGAGCTGGACGCCGACTACTGGTGGCGCAATGTGCGCGAGGCCGTGCACTTCCGGGCCGCCGTGGACCGGCTGCTGGACGACGGCTACGGCGTCTTCCTGGAGATCGGCCCGCACCCCGTGCTCGCGCACTCCCTGCGTGAGTGCTGCGAGGCCGGCGACGCGCACAGCGTCACCCTGGCCTCCATCCGCCGCAAGGCCGACGAGCGCGAACGCCTCACCCTGTCGCTCGCCGCGCTGCACAGCCTCGGCTTCGCCGTGGACTGGCACGCCCTGCACCCCGCCGGACGCCCGGCCGAACTGCCGCGCTACCCGTTCCGGCGCGACCGCTACTGGGTCGAGCCGGCCCCGGTCGCGCAGATCCGGCTCGGCCACCGCGACCACCCGCTGCTGGGGCGCCGCACCGCGAGCGCCGAGCCGGTGTGGGAGGTGAAGCTGGACGCGGAGGCCGCCCCGTACCTGGAGGACCACCGCATCCAGGGCACCGTGCTGTTCCCGGCCGCCGGCTATCTGGAGATGGCCGCGCAGGCCATGCGGTCGCTGACCGGTGGTGAGCACAGCACCGCCGCGCTGGCCGGCGTCGAGCTGCGCAAGGCGCTGTTCCTGCCGGACGGCGAGCCGCAGACGGTGCAGCTGTCCTTCTCCTCCGACGCCGCCGCGTTCTCCATCGCCACCGTGGGCGCGCCCGGCGCCGAGCCGACCGTGCACGCCACCGGTACGGTACGGGCCGCCCAGCGCCGCCGGCTGACCGCGCCGCTGGACACCGTCGCCGTCCGGGCCCGCGCCGCCCGCCATCTGAGCGGCCCCGACTGCTACGCCGAACTGGCCGCGCTCGGCTACCACTACGGCCCCGCCTTCCAGGGCATCGAGGAGGTGTGGATCGGCGAGGGCGAGGCCCTGGCGCGGATCCGGCCGCCGCAGGGGCTCGCCCCGGACGCGGCGGCGCACCACATGCATCCGGTGCTGCTCGACTCCTGCTTCCAGTCGCTGCTGACCCCGCAGTTGCTCACCGCGCCCGCCGGGCCCGGGGGCACCGGCATCCGGCTGCCGCTGTCCATCGCCGAGGTACGGCTGGACCCGGTCGGCGACCGCGAACTGTGGGTGCACGCCACCGTCACCGGTGAGGACGAGGACGAACTCACCGGGGACATCGCCGTGTACGACGGCGCCGACGGCACGCCGCTGGGCCGCATCGCCGGATTCCGCGCCGCCGACGTGGAGAAGGCCGCCACCACCGTGGGGCTGTCCACCATCGACAGCTGGCTCACCGAACTGAGCTGGGTGCCGCGTCCCCTGCCCGAGGCACCGTCCGCCCTGCCCGCGGCCGGGCGGCACGTGCTGTTCGCCGACGCGGGCGGGGTCGCGCGGCGGCTGGCCGCGCTGATCGGCGAGGCCGGCGGCGAGGTGCTTCTGGTGCGGCCCGGTGCCGCGTACGGCTTGGACAGCACGGCGCGCACCGCCACCGTCGTCCCCGGATCCGCGGATGACCTGCGGCGGTTGCTCGCCGATCTCGGCCCGGTGGACGGCGTCGTCCACCTGTGGAACCTGGACCGGCCGGCGCTGGCCGACGCGCCGCGCGGGCGGTTCGCGGACATCGCCTCCACCGGCGCGTACGCCCTGATCGCCCTCACCCAGGCGCTGCTCGCCGACCCGGAACGGCACGGCGGCACCCCCGTGCACATCGTCACCAGAGCCGCCCAGTGCGTGCTCCCCGGTGAGCCGGTGGAGCCGCTGGGCGCGCCCGCCTGGGGCATCGGCCGGGTGCTGTGGCAGCAGGAACTGGCCGGGCGCGGCGGCAAGCTGATCGACCTGGCGGCCGACGGCGACATCGAGGAGGACGCGTCCGCGCTGCTGCGCGAACTGGCCGACCCCACCGGGGCCGCCGAGCGCGAGGACGAGATCGCGCTGCGCGCCGGGGAGCGGCACACCAGCCGGCTGGTGGCCGCCGAAGGGCTGAGCAGGCCGCTGCCCCTGCGGCTGCGCCCGGACGGCAGCTACCTGGTGACCGGCGCGTTCGGCGCGCTCGGCAGGCTGCTGTGCCGCACGCTGGTCAGGCGCGGGGCGCGGCGGCTGATCCTGGTGGGCCGCACCCGGCTGCCGGAGCGCGAGCGCTGGGCCGACCAGGACCCGAACTCGCCCGCCGGGCGGCACGTGGCCTTCCTCAAGGAGCTGGAGGCGCTGGGCGCGCAGCCGATTCTCGCGCCGCTGGACATCACCGACGAGGACGCGCTGGCCGGCTGGCTGGCCGGGTACCGGCGCGCCCAGGGCCCGCCGATCCGCGGGGTGTTCCATCTGGCCGGGCAGGTGCGCGACACCCTGGTGCCGGAGATGGACCGGGAGGTGTTCGACGCCGTCCACGACCCGAAGGTGGTGGGCGCGGCGCTGCTGCACCGGCAGCTGAGCGGCGAACCGCTGGAGCACTTCGTGCTGTTCGCCTCGGTCGCGGCCTGGCTGACGACGGCCGGGCAGACCAACTACGCGGCGGGCAACGCCTTCCTGGACGCGCTGGCGCACCACCGCCGCGCGCAGGGCCTGCCGGCGCTGGCGCTGGACTGGGGCCCGTGGGCCACCGGCATGATCGAGGAACTGGGCCTGATCGACCACTACCGCAACAGCCGGGGCATGTCCTCGCTGGCGCCCGAGGCGGGCATGGCGGTACTGGAGCGGGTCATCGGGCAGGACCGGGCGCAGCTGCTGGTGGCCACGGTCGTGGACTGGCCGGTGTTCATGTCCTGGTACGCCTCGCCGCCGCGGCTGGTCACGGAGCTGGCGGCCACCGCCCAGGGCCCGGGGTCCGAGGGCGACGGCAGTTTCCTGGACGCGTTCCGGGAGACGACCGCGGACAAGCGGCGGCTGCTGCTGACCGAGCGGTTCACGACGCTGGTGGCGGGTGTGCTGCGCGTGCGGGCCGAGCAGGTGGATCCGGCGGTCAGCCTGAATCTGCTAGGGCTCGACTCGCTGCTGGCGATGGAGCTGCGGGCCCGGGTGGTGGCCGAGGTGGGCATCGCGCTGCCGGTGGTGGCGCTGCTGTCCAGCGCGCCGGCCGGGGACCTGATCACCCAGCTGCACGAGGGCCTGGAGGAGTTGCTGGCCGAGGAGGGCAGCGGCGCCGCCGTGACGGCGGTGGAGCGGTTCGAGGACGAGGCCGAGTTCCCGCTGACGCAGAACCAGAAGGCGCTGTGGTTCCTGAAGCAGCTGAACCCGGACGGTTACGCGTACAACATCGGCGGGGCCGTCGAGGTGCGGGTCGAGCTGGACCCGGACCTGATGTTCGAGGCGTTCCGCCGGCTGCTGGCCCGGCATCCCGTGCTGCGGGCGAACTTCCTGCTGGTGGAGGGGCAGGCGGTGCAGCGGATCTCCCCGGAGATCAAGGAGGACATCGCGCTCTTCGACGTCGGGGACCGCGCGTGGGACGACATCTACCGGATGATCATCGAGGAGTACCGCAAGCCGTACGACCTGGCGACCGATCCGCTGATCCGGTTCCGCCTCTTCCGGCGCGGCCCGGACCGCTGGGTCATCACCAAGGCCGTCCACCACATCATCTCGGACGCCATCTCCACCTTCACCTTCATCGAGGAACTGCTGTCCCTGTACGAGGGGCTGCGGCAGGGCCACGACGTCGAACTGCCGCCGGTGTCGGCCCGCTACCTGGATTTCCTCAACTGGCAGAACGCGTTCCTGGCCGGCCGCGAGGCGCAGAAGATGCTCGCGTACTGGCGGGGGCAGCTGCCGGAGGAGGTGCCGGTGCTGGCGCTGCCCACCGACAAGCCGCGCCCGGCGGTGCTCACCCACAACGGGGCGTCCGAGTTCTTCGCGCTGGACGCGGAGCTGAGCGCCCGGGTGCACGCGCTGGCGCGGGAGCACAACGTCACCGTCTTCATGGTGCTGCTGAGCGCGTACTACCTGCTGCTGCACCGCTATTCGGGGCAGGACGACATCATCGTCGGCTCCCCCGTCACCGGCCGCACCCAGGAGGAGTTCGGCTCCGTCTACGGGTACTTCGTGAACCCGCTGCCGCTGCACGCCTCGCTGGCCGGTGACCCCACGGTGGCCGAGCTGCTGGACCAGGTGCGCACCACCGTGCTGGGCGGCCTGGATCACCAGGAGTACCCGTTCACGCTGCTGGTGGAGCAGCTGGGGCTGGCCCACGACCCGAGCCGGTCGGCGGTCTTCCAGGCGATGTTCATCCTGCTGCACCACAAGGTGGCCACCGAGAAGTACGGCTACAAGCTGGAGTACATCGAGCTGCCCGAGGAGGAGGGCCAGTTCGACCTGACGCTCTCCGCGTACGAGGAGGAGGCGGACGGGCGGTTCCACTGCGTCTTCAAGTACAACACCGACCTCTTCGAGGCGGAGACGATCCAGCGGCTCGCCGGGCACTACACGCGGCTGCTGGAGTCGCTGACCGCCGCGCCCGCCGACGCCGCCACCGGTGGACTGCGGATGCTGTCGGGCGGTGAGCGGGAGCGGATCCTCACCGGGTGGAGCGGTGCCGAAGTGCGCGCGCAGGAGGCGCCGGTGCCGGTGCACCGGCTGATCGCCGAGGCGGCGCACCGTACCCCGCAGGCCGTCGCGGTGGCCGCGCCCGCCGAGAGCGGGGAGACCCGGCGGCTGACCTACGGCGAACTGGAGGAGCGCGCGGGCGAACTGGCCGGGCGGCTGCGGGCGCGCGGCGTGCGCGAGGGCACCGTCGTCGCGCTGTGCCTGGAGAAGTCGCCCGAGCTGATCACCGCCTTGCTGGCGGTCCTCAAGGCGGGCGGCGCCTATCTGCCGCTGGACCCGGACTATCCGGCCGACCGGCTCGCGTACATGGTGCGCAACGCCGGGGCCGCGCTGGTGATCGGCGGGACGGGCGGCGCGGCCGAAGGGCTGCCGGGCACCGTGGTCAGCCTGGAGGAACTGCTCGCGGGCGAGGCCGGCGAGGTGGTTCCGGACGCCGAGCCGGGGCCCGACTCCCCCGCCTACGTCATCTATACCTCCGGCTCCACCGGGCGTCCCAAGGCGGTCGCGGTCAGCCACCGCAACCTGGCCTCCGTGTACGCCGGATGGCGCGACGCCTACCGTCTGGAAGAGGGAGACATCCGGGTCCATCTCCAGATGGCCAGCCCTTCCTTCGACGTCTTCACCGGCGACCTGACCCGCGCCCTGTGCTCGGGCGGCACGCTGGTGCTGGTCGGCCGGGAGCTGCTGTTCAACACCGCCCGGCTGTACGAGACGATGCGCGCCGAACGGGTGGACTGCGGCGAGTTCGTGCCCGCCGTGGTGCGCACCCTGGTGCGGCACTGCGAGGACACCGGGGCCCGGCTGGACTTCCTGCGGCTGCTCATCGTGGGCTCGGACTCCTGGAAGGCCGAGGAGTACGAGCGGCTGCGCGCCCTGGGCGCGCGGCGGCTGGTGAACTCGTACGGGCTCACCGAGGCCACCATCGACAGCGCCTGGTTCGAGGGTCCCGCGGACGACCTGGAGGGCGGCCGGATGGTGCCCATCGGGCGGCCGTTCCCGGGCAGCGCGCTGTACATCCTGGACTCGCGCGGCGAGCCGGTGCCGCCCGGTGTCCCCGGTGAGCTGTGGATCGGCGGCGCCGGTGTGGCGCTCGGCTACCTCGGCGACGAGGAGCTGACCGGGGAACGGTTCCGCACCCGCACCCTGGCCGGCGACGCTCCGGTACGGCTGTACCGCACCGGTGACCTCGCACGGTGGGACGCGGCCGGCACCGTCCATCTGCTGGGCCGGGCCGACTCGCAGATCAAGGTGCGCGGGCACCGCATCGAGATCGGGGAGATCGAGTCGCAGCTGGCGGCCTGCCCCGAGCTGGCCCAGGCGCAGGTCACCGTACGGCCGGACGCGGGCGGCGAGAACGTGCTGTGCGCGTACGGGGTGGCGGCACCGGGCGCCGTGCTGGACTGGCGCGAGGTGCGCCGGCGCCTGGCGGACTATCTGCCGACGTTCATGATCCCCACCCACTTCACCGAGTTGCCCGCTCTGCCGCTCACCCCGAACGGCAAGGTGGACGTGGCGGCGCTGCCCGCCCCGCGCGCCGGCGACGGCGCGGACGGGCCGGTGTACGAGGCCCCGGTCACGCTGTACGAGACGCGGATGGCCGAGCACTGGCAGCGGCTGCTGGGCATCGAGGCCCCCGGCCCCGGTCTGGGCCACGACTTCTTCGAGACCGGCGGCAGCTCCATCCGGCTGATCGAGCTGATCTACCACCTGCAGGCCGAGTTCGGGATCTCCATCCCGGTCAGCCGGCTGTTCCAGGTGACGACGCTGCACGGCATGGCCAAGACGGTCGAGCGGATCGTCACCGGGGAGATCGAGGGGTCGCTGCCGTATCTGCGGTTCAACGAGAACGCCGCGGCGGGCACGGTGTTCTGCTTCCCGCCGGCCGGTGGCCACGGCCTGGTCTACCGGGAGTTCGCGGCGCGGCTGCCGGAGTTCGAGTTCCTCGCCTTCAACTACCTGATGGGCGAGGACAAGGTGAGCGGGTACGCCGATCTGGTGGCCGGGCACCGGCCGGAGGGCGAGATCGACCTGCTCGGCTACTCGCTGGGCGGCAATCTCGCCTTCGAGGTCGCCAAGGAGCTGGAGCGGCGCGGCCGCACCGTGCGGCACGTCGTCATCATCGACTCGCTGCGGGTGACGGAGTCCTACGAGCTGGGTCCGGAGCACCTGGCCGTCTTCGAGCGCGAGCTGGCCGGGCATCTGCGCAAGCACACCGGCTCGGCACTGGTCGCGGAGAAGACGCGGGAACAGGCCAAGGACTACCTGGAGTTCACCGGCCGCACCGCCAACCCCGGGACCACCGGCGCCCGGATCGCGGTGATCAGCGACGAGGAGAACGCCGCCGCGTACGACAGCGGCGCCGAGGGCAGCTGGCACGGCGCCTCCCGTACCGGAACCGAAGTGCTGCGCGGGGTGGGCCGGCACGCCGACATGCTCGATCCGGGGACGGTCGAGCACAACGCGCGCCTGGCGCGCGGCATTCTCACCGGCGGTGATGGCGAGGTATGA	MDSMHHPAPVPVPEVPTPVPSQDDAFAIVGIGCRLPGGASDYRTFWRNLLDGKDCITDTPADRYDTRTLGSGDKAKPGRLVGGRGGYIDGFDEFDPAFFGISPREAEHMDPQQRKLLEVAWEALEDGGLKPAELAGTDVGVYVGAFTLDYKILQFADLGFETLAAHTATGTMMTMVSNRISYCFDFRGPSVSVDTACSGSLVAVHLACQSLRRGETSVALAGGTLLHMAPQYTIAETKGGFLSPDGRSRALDAAANGYVRAEGVGMVAIKRLADAQRDGDPIHAVIIGSGVNQDGRTNGITVPNPDAQVALIERVCAGAGVTPGSLQYVEAHGTSTPVGDPLEANALGRALSIGREPGARTYVGSVKTNIGHTESAAGIAGLIKTVLSLKHKIIPPHINLEKLNPQIDEASLPYEIPREPTPWPEHSGPARAGVNSFGFGGTNAHVLLQEAPPTAEEPAPPATDGYSVLPLSARDPEAFPAIAAGLRERLAEGLPVGDAAYTLAHRRQHLEQRLSVVYDSPEALDEVLGAVARGESHPRAVAGTQREGLDRRLVWVFTGMGPQWWAMGRQLYASEPVYREVIDRCDQEIAALTGWSLTQELNADEADSRMSETWLAQPANFAVQIALAALWRSKGVQPDAVTGHSTGEVAAFYEAGVYTLPEAVKIVVHRSRLQQKLIGTGSMLAVSLTEAEAARRVRPHGDRVSIAAVNSPTSITLAGDTEALEVIAAELGAEDIFARFLEVGVPYHSPRMELIKDELLTSLADLKPQQAKLPLYLTALPGTVAQGTELDADYWWRNVREAVHFRAAVDRLLDDGYGVFLEIGPHPVLAHSLRECCEAGDAHSVTLASIRRKADERERLTLSLAALHSLGFAVDWHALHPAGRPAELPRYPFRRDRYWVEPAPVAQIRLGHRDHPLLGRRTASAEPVWEVKLDAEAAPYLEDHRIQGTVLFPAAGYLEMAAQAMRSLTGGEHSTAALAGVELRKALFLPDGEPQTVQLSFSSDAAAFSIATVGAPGAEPTVHATGTVRAAQRRRLTAPLDTVAVRARAARHLSGPDCYAELAALGYHYGPAFQGIEEVWIGEGEALARIRPPQGLAPDAAAHHMHPVLLDSCFQSLLTPQLLTAPAGPGGTGIRLPLSIAEVRLDPVGDRELWVHATVTGEDEDELTGDIAVYDGADGTPLGRIAGFRAADVEKAATTVGLSTIDSWLTELSWVPRPLPEAPSALPAAGRHVLFADAGGVARRLAALIGEAGGEVLLVRPGAAYGLDSTARTATVVPGSADDLRRLLADLGPVDGVVHLWNLDRPALADAPRGRFADIASTGAYALIALTQALLADPERHGGTPVHIVTRAAQCVLPGEPVEPLGAPAWGIGRVLWQQELAGRGGKLIDLAADGDIEEDASALLRELADPTGAAEREDEIALRAGERHTSRLVAAEGLSRPLPLRLRPDGSYLVTGAFGALGRLLCRTLVRRGARRLILVGRTRLPERERWADQDPNSPAGRHVAFLKELEALGAQPILAPLDITDEDALAGWLAGYRRAQGPPIRGVFHLAGQVRDTLVPEMDREVFDAVHDPKVVGAALLHRQLSGEPLEHFVLFASVAAWLTTAGQTNYAAGNAFLDALAHHRRAQGLPALALDWGPWATGMIEELGLIDHYRNSRGMSSLAPEAGMAVLERVIGQDRAQLLVATVVDWPVFMSWYASPPRLVTELAATAQGPGSEGDGSFLDAFRETTADKRRLLLTERFTTLVAGVLRVRAEQVDPAVSLNLLGLDSLLAMELRARVVAEVGIALPVVALLSSAPAGDLITQLHEGLEELLAEEGSGAAVTAVERFEDEAEFPLTQNQKALWFLKQLNPDGYAYNIGGAVEVRVELDPDLMFEAFRRLLARHPVLRANFLLVEGQAVQRISPEIKEDIALFDVGDRAWDDIYRMIIEEYRKPYDLATDPLIRFRLFRRGPDRWVITKAVHHIISDAISTFTFIEELLSLYEGLRQGHDVELPPVSARYLDFLNWQNAFLAGREAQKMLAYWRGQLPEEVPVLALPTDKPRPAVLTHNGASEFFALDAELSARVHALAREHNVTVFMVLLSAYYLLLHRYSGQDDIIVGSPVTGRTQEEFGSVYGYFVNPLPLHASLAGDPTVAELLDQVRTTVLGGLDHQEYPFTLLVEQLGLAHDPSRSAVFQAMFILLHHKVATEKYGYKLEYIELPEEEGQFDLTLSAYEEEADGRFHCVFKYNTDLFEAETIQRLAGHYTRLLESLTAAPADAATGGLRMLSGGERERILTGWSGAEVRAQEAPVPVHRLIAEAAHRTPQAVAVAAPAESGETRRLTYGELEERAGELAGRLRARGVREGTVVALCLEKSPELITALLAVLKAGGAYLPLDPDYPADRLAYMVRNAGAALVIGGTGGAAEGLPGTVVSLEELLAGEAGEVVPDAEPGPDSPAYVIYTSGSTGRPKAVAVSHRNLASVYAGWRDAYRLEEGDIRVHLQMASPSFDVFTGDLTRALCSGGTLVLVGRELLFNTARLYETMRAERVDCGEFVPAVVRTLVRHCEDTGARLDFLRLLIVGSDSWKAEEYERLRALGARRLVNSYGLTEATIDSAWFEGPADDLEGGRMVPIGRPFPGSALYILDSRGEPVPPGVPGELWIGGAGVALGYLGDEELTGERFRTRTLAGDAPVRLYRTGDLARWDAAGTVHLLGRADSQIKVRGHRIEIGEIESQLAACPELAQAQVTVRPDAGGENVLCAYGVAAPGAVLDWREVRRRLADYLPTFMIPTHFTELPALPLTPNGKVDVAALPAPRAGDGADGPVYEAPVTLYETRMAEHWQRLLGIEAPGPGLGHDFFETGGSSIRLIELIYHLQAEFGISIPVSRLFQVTTLHGMAKTVERIVTGEIEGSLPYLRFNENAAAGTVFCFPPAGGHGLVYREFAARLPEFEFLAFNYLMGEDKVSGYADLVAGHRPEGEIDLLGYSLGGNLAFEVAKELERRGRTVRHVVIIDSLRVTESYELGPEHLAVFERELAGHLRKHTGSALVAEKTREQAKDYLEFTGRTANPGTTGARIAVISDEENAAAYDSGAEGSWHGASRTGTEVLRGVGRHADMLDPGTVEHNARLARGILTGGDGEV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	561.87	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0001435.1|Ikarugamycin_7 # 12782 # 14614 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0001435.1|Ikarugamycin_7 	12782	14614	+	Loose	750	31.187	tet(52)	30.95	3004587	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACGCCTTTCGTTCAGCCGGCGGTCGACACCAAGGAGCACAGGGCCATGTCATCCCCCACCACCTCCGGCACCCCGGGCAGGCAGTCGATGATCATCATCGGCGGCGGCCTGGGGGGCCTGTCCACCGGCTGCTACGCGCAGATGAACGGCTACGCGACGCGGGTCTTCGAGATGCACGAGATCCCGGGCGGTTCCTGCACCGCCTGGGAGCGCGGGGACTTCACCTTCGACTGGTGCGTCAGCTGGCTGCTCGGCAGCGGTCCCGGCAACGAGATGTACCAGATCTGGATGGAACTGGGGGCGTTGCAGGGCAAGGAGATGCGCCAGTTCGACGTCTTCAACATCGTGCGGGTGCGCGGCGGCCAGCCGGTGTACTTCTACTCCGACCCGGACCGGCTCCAGGCGCACCTGCTGGAGATCTCCCCGGCCGACGCCCGCCGCATCAAGAACTTCTGCGACGGGGTACGCACCTTCCAGAAGGCGCTGGCCGTCTATCCGTTCCTCAAGCCGGTGGGGCTGATGGGGCGGTGGGAGCGGTGGAAAATGCTGGCCTCGTTCCTGCCGTACTTCAACGCCATCCGCAAGTCCATCACCGAGCTGATGACGGACTACGCCGAGAAGTTCCAGCACCCGGTGCTGCGCGAGGCGTTCAACTACGTGCTGTACGAGAAGCACGCCGACTTCCCCGTCCTGCCGTTCTGGTTCCAGCTGGCCTCGCACGCCAACGGCTCGGCGGGGGTGCCCGAGGGCGGCTCGCTGGAGCTGGCCCGCTCGGTGGAGCGGCGCTACACGGGGCTCGGCGGGGAGATCACCTACAACGCCAAGGTGGAGAAGATCCTCGTCGAGCACGACAAGGCGGTGGGGGTACGGCTCACCGACGGCCGCGAGTTCCGCGCGGACATCGTGGTGTCGGCGGCCGATCTGCACACCACCGCCATGGGGATGCTCGGCGGCCGGTATCTCAACGACACCTGGCGCAAGCTGCTCACCGAGACCATCGACGAGGTGGGCACGATCTCCCCCGGCTACGTCTCGCTGTTCCTGGGGCTGCGCCGGCCGTTCCCCGAGGGCGAGCCGTGCACCACGTACGTGCTGGAGGACAGCATGGCGGCGAAGCTCACCGGCATGCGGCATCCCAGCATGAACGTGCAGTTCCGCAGCTGCCACTACCCGGAGCTGTCGCCGCGCGAGACCACGGTCATCTTCGCCACGTACTTCTCGGAGGCCGAGCCGTGGCGGGCGCTGCGCGACGACGTGCCGGAGCAGGCGGGCCGGGTGCGGCGCGGCCAGGTGCTGCACACCCTGCCGGTGAAGCACGGCAAGGCGTACACGCAGGCCAAGCGGCAGGCGCGGATCACCATCGAGAACTTCCTGGACGAGCGGTTCCCCGGTCTCAAGGACGCGGTCGCCGTGCGGGACGTGTCCACGCCGCTGACGCAGGTGCGCTACACGGGCACCTACAACGGCGGGTTCCCCGGCTGGCAGCCATTCGTGGACGGCGGGGAGACCGTGGAAGTGGAGATCAACAAGAACGGCCCGGTGCTGCCGGGGCTTTCCAACTTCTATCTGGCCGGGGTGTGGGTCACCGTCGGCGGGCTGATCCGGGCGGTGGCCTCGGGCCGGCAGGTCACGCAGGTGATCTGCCGGGACGACGGCCGGGAGTTCACGGCGAGCGTGGACGAGAGCGCGCCGCCGCCCACCCAGGTCTCCATCGCGGTGGGCAAGCAGCCCGGCGTGCCGGATCTGGCCGCCGGGTTCCCCGCCCAGACCACCGGCGGCGACACCGCCGCCCACACCGACAACACCGTCACATCGTCGAGGAGCGTGTAG	MTPFVQPAVDTKEHRAMSSPTTSGTPGRQSMIIIGGGLGGLSTGCYAQMNGYATRVFEMHEIPGGSCTAWERGDFTFDWCVSWLLGSGPGNEMYQIWMELGALQGKEMRQFDVFNIVRVRGGQPVYFYSDPDRLQAHLLEISPADARRIKNFCDGVRTFQKALAVYPFLKPVGLMGRWERWKMLASFLPYFNAIRKSITELMTDYAEKFQHPVLREAFNYVLYEKHADFPVLPFWFQLASHANGSAGVPEGGSLELARSVERRYTGLGGEITYNAKVEKILVEHDKAVGVRLTDGREFRADIVVSAADLHTTAMGMLGGRYLNDTWRKLLTETIDEVGTISPGYVSLFLGLRRPFPEGEPCTTYVLEDSMAAKLTGMRHPSMNVQFRSCHYPELSPRETTVIFATYFSEAEPWRALRDDVPEQAGRVRRGQVLHTLPVKHGKAYTQAKRQARITIENFLDERFPGLKDAVAVRDVSTPLTQVRYTGTYNGGFPGWQPFVDGGETVEVEINKNGPVLPGLSNFYLAGVWVTVGGLIRAVASGRQVTQVICRDDGREFTASVDESAPPPTQVSIAVGKQPGVPDLAAGFPAQTTGGDTAAHTDNTVTSSRSV	MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH	156.41	gnl|BL_ORD_ID|2698|hsp_num:0	3289			279	528	tetracycline; oxytetracycline
BGC0001435.1|Ikarugamycin_8 # 14632 # 15678 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0001435.1|Ikarugamycin_8 	14632	15678	+	Loose	660	43.1282	MexS	31.9	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATCGCCGAGCACATCCCGGGGGTCCCGGACACCGACCGGATCTACCGGAAGGTGACGCGGGAGTTCGATCCCGCCTCGCTGGCGGACGATCAGATGCTGCTGCGCACCCGGTACGTGTCGGTGGACCCCTACCTGGTGGGGCTCTCCCTCCAGACGCCGATCGGGGACACCGTGCGCGGTGACTCGATCATGGAGGTGGAGGTGGCGGGGCCGCGCGCCCGCTTCCAGGTCGGGGACCTGGTGCAGGGGTACGGCGGCTGGTGCAGCCATCTGGTGTCCACCGGGGGGCCCAGCGGGTGGGACGACGAGGGCGCCGAGTTCGCCGTCCAGTTGCCGCCGTTCCGCAAGCTGGACCCGCGCCGGTACGACGAGGTGCTGCCGCTGTCCACGGCGCTGGGCGTGATGGGCACCCCGGGCATCACCGCGTTCGGCACACTCAAGACGTTCCTGACGGTGGGCTCAGAGGACACCGTGGTGATCAGTGGCGCGTCCGGGACGGTGGGCACCCTGGTGGGTCAGCTCGCCAAGCGGGCCGGGGCCCGGGTGGTGGGCACCACCTCCTCACCGGGGAAGGCCGCGTATCTGACGCAGCTGGGCTTCGACGCGGTGGTGCACTACCGGCAGGGCGACGACACGGACACGGTGCGCGAGGCCCTGGCGGCGGCGGCGCCCAACGGGATCGACAAGTACTTCGACAACCTGGGCGGCACCGTGACGGACGCGGTGTTCACGATGCTCAACGTGCACTCCCAGGTCGCGGTGTGCTGGCAGTGGGCCACCACGGTCAACGGGGACTGGACGGGGCCGCGGCTGCTGCCGTACATCATGTTCCCGCGCACCACGATCCGCGGGATCTTCGCCGACGAGTGGTACACCGAGGAGATGGTCGACGCGCTGCACGAGGAGGTGGGCGGGCTGATCCGCAAGGGCGAGCTGGTCTACCACCAGACCATCCACCAGGGCTTCGACGCACTGCCCGGCGCGTACCGCTCCCTGTACACCGGCCAGGAGGGCAACCGGGGCAAGGTCCTGGTCGCGCTGTAG	VIAEHIPGVPDTDRIYRKVTREFDPASLADDQMLLRTRYVSVDPYLVGLSLQTPIGDTVRGDSIMEVEVAGPRARFQVGDLVQGYGGWCSHLVSTGGPSGWDDEGAEFAVQLPPFRKLDPRRYDEVLPLSTALGVMGTPGITAFGTLKTFLTVGSEDTVVISGASGTVGTLVGQLAKRAGARVVGTTSSPGKAAYLTQLGFDAVVHYRQGDDTDTVREALAAAAPNGIDKYFDNLGGTVTDAVFTMLNVHSQVAVCWQWATTVNGDWTGPRLLPYIMFPRTTIRGIFADEWYTEEMVDALHEEVGGLIRKGELVYHQTIHQGFDALPGAYRSLYTGQEGNRGKVLVAL	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	102.65	gnl|BL_ORD_ID|1039|hsp_num:0	1041			339	672	ciprofloxacin; trimethoprim; chloramphenicol
BGC0001435.1|Ikarugamycin_9 # 15811 # 16281 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0001435.1|Ikarugamycin_9 	15811	16281	-	Loose	275	42.743	AAC(6')-Isa	32.94	3002563	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGATCGGATACGGCCGCCAGGCCCCCGAAAGTCTCGACGCCAGGACCGAGGGCATGCGCCGGCAGCAGGGCGGCGACAATATCCGCTTCACCCTCTACGACCTCACCACCGGCGGTGAGCCGACGCCGGCCGGGGTGGCCACTCTGCTGCCCGACCACAGCGTCCGCTGTGCGGAGTATGTCGTTATGCTCGGCAACGAGTTCCGCGGGCACGGCCTGGGGACGGCCGCCACCCGGCTCGTTCTGGACTACGCCTGGCACGTCACGAACCTGCGGATGGTCTGGCTCTCCGTCCTCGCCCCGAACGCCGCCGCGCTCCGCGCCTACGAGAACGCGGGTTTCCAACCGGCCGGCCGACTTCGTCAGGCCGGGTACTGGCGAGGCAAGCCGTGCGACGAGATCATCATGGACGCCCTCGCATCGGACTTCACGGGTCTCTCCGTCATCTCCGACCCCGCACAGCCTTCTTGA	MIGYGRQAPESLDARTEGMRRQQGGDNIRFTLYDLTTGGEPTPAGVATLLPDHSVRCAEYVVMLGNEFRGHGLGTAATRLVLDYAWHVTNLRMVWLSVLAPNAAALRAYENAGFQPAGRLRQAGYWRGKPCDEIIMDALASDFTGLSVISDPAQPS	MELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYEETDPEFHHAGIDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSYRKVGFRPVGIMRAYGRDHRTGRWQDALLMDLLADELT	99.36	gnl|BL_ORD_ID|886|hsp_num:0	967			216	471	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001435.1|Ikarugamycin_10 # 16379 # 17107 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=12bp;gc_cont=0.712	BGC0001435.1|Ikarugamycin_10 	16379	17107	-	Loose	500	29.261	OXA-207	21.15	3001485	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTCTGATCCGCCCGCTCATGCCACCTGTCCCCCGAGCGTCCGCGCGGTGGACCTCGGGCATGTCCTGGTTCTCATCAACTACCGTTCTGGCAGGGCACAATGCCTCCTGCCCGCCGCTGCGCTGCGGTGGTGTGCCGCAGCCCGTACCGGCGACCTCACCCCACTCGGAGACACGCTCACCAGCCGTTTGCTCGACCTGGGCCTGATTGTTCCCACAGAGCACCCCCAGCCGTGGCCCGCCCTCATCCCGGCCACTGCCCGAGTCGGTGGAGGCGGCGACGAGCACCGCGCCGGTATCGTCCGGCCGGCCCATGTCCCTCTCCGCTCTGTTGTCCGAGCGGGCGCGGCTCTCGCCCGGGTCTTCGTGGTCACCAGGGGGACTCAGGGCATGCAGCGGATCATCTCCCTGCTCAACTACGCCAACACCAATGTCCGCTGCAACCGCCCGGCTACCGAGGCCGAAGCCACCGCCGCGGTGCAGGCGGTCCGCCGGGCAGGCTGGTACTCGCCGGGCAGAACCGCGTGTCTGGAGGAGTCGGCCGCCGCCCTGCTGCTGCTGGCCGCTCAGGGCCGCAGGGCCCAGTGGTGTCATGGCGTCGCGCCAGACCCGGTGCGGCTCCATGCCTGGGTGCAGACTGTGGACGGCGCCACCGTCGCCGAGCCGGGGTCCACCGGCGCCTACACCCCCGTCCCCACCATCGGAGACCGCCATCAGCACCCCGACTGA	MSDPPAHATCPPSVRAVDLGHVLVLINYRSGRAQCLLPAAALRWCAAARTGDLTPLGDTLTSRLLDLGLIVPTEHPQPWPALIPATARVGGGGDEHRAGIVRPAHVPLRSVVRAGAALARVFVVTRGTQGMQRIISLLNYANTNVRCNRPATEAEATAAVQAVRRAGWYSPGRTACLEESAAALLLLAAQGRRAQWCHGVAPDPVRLHAWVQTVDGATVAEPGSTGAYTPVPTIGDRHQHPD	MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEGKNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMTLGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEVNFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWVMGVTPQVGWLTGWVEQANGKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII	88.00	gnl|BL_ORD_ID|705|hsp_num:0	767			420	732	cloxacillin; oxacillin; cefalotin
BGC0001435.1|Ikarugamycin_11 # 17100 # 18908 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=CCC;rbs_spacer=12bp;gc_cont=0.716	BGC0001435.1|Ikarugamycin_11 	17100	18908	-	Loose	700	26.9498	PDC-160	32.67	3006539	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGTTCTTCGGAGGATTCACGGTCGGTTGTAGTGACGGGCTCCGCCCTCATGGCACCGAATACGCCGACGCGGCCCGCTCCGTGTGGAGCGGCCCGATGATGGTCCGGGCCGTCAGCGGAGCAGACGGCGGCACGGTGATGGTGCTGGGGCGTTGCGGTGCGTCCGAAGCCGAGCTGGGCACGGTGGCCGGCGGGCAGCTGCCGGAGGATGTGACCTGGCGGTGGCCCGGTACCTACACCGTCGTGGAGCACCGGGCCGAAGGCGTCGTGCTGCATACCGATCCGGCCGGGGCCATGCCCCTCTACACGGCGGAGTTCGGGGGCGGCTGGGCCTGGTCGAGCTCGGCCCGGGTTCTCGCCACGCTGACCGGGGCCGCTCTCAGCGCGGAACGCCTGGCGGTATCGGTCTTCGCTTCGTACGTTCCGGCGGCCGGTGCTCGGTCCTTCTTCACCGGTGTACGGCTGCTGCCACCGGGCTCGCGGGTGTGGCTGCCTTCGGACGGGGGCACGCCACGCTGTACAACCGTGTGGCGGCCGGACCCGGTGCCGGGTGATCCGGCCCGCCGATTCCGGGTCGTGCTCCAGGCCGCGGTCGAGTACCGGACGGTCCTGGACCCAGAGGTGTCGTGCGATCTGTCGGGCGGGCTGGATTCCAGCACATTGGCACTGCTCGCCGCTGCGGCCCGTCCCGCCGAGGGCCACCTGAACGGCGTCACCGTCCACCCGGACGACGACACCAGCGGTGCCGACCTCCACTACGCGCGGCTGGCGGCCGCCCGCGACCCCCGGATCGCGCACCACCTGCTCTCCCTCGGCACCGAGCAACTGCCCTACACGGACATCACCGCGGTGCCGGCCACCGACGAGCCCGCCCCTTCCACCCTGGCCCGCGCCCGTCTGGAATACCAACTCGACTGGATGAAGTCCGAGTTCGGCACACGCACGCACATGACCGGCGACGGCGGAGACAGTGTGCTGTTCGTACCGCCCGCTCACCTCGCCGATCTGCTGCGGCATCGCCGGTGGGCACGGGCGGTGAGCGAAGCGACGGGCTGGGCCCGGCTGCGGCACACAGCCGTCCTGCCACTGCTGAACAATGCCCGTCGGCTGGCCGGTGTCAGCCGGGCGGATGCCTTCGCCGACCTCGCGCACACCGTGGAGGGCGCCGGCCACCCCGCCGGGGAGGACCGGGGTGATGTCACCTGGGTGCCGCAGCTCCCGATGCCACCGTGGATCACCGAGAAGGCTCGCAGCCTGCTTGCCGGCGGACTCCGGCGCGCCGCCGCCGAAGCGGACCCCCTGCCCGGCCTGGACCTCGGGCCCCGGGTCCTGGTGGATGAGATCCGGGAGCTCGCCCGTACTGCGGCCGCCGACGCCCAGTTGGCCGACCAGCAGGGCGTTGAGCTGCACAATCCGTTTCTGGACGCGCACGTTGTCGATGCGGTGCTGCGGACCGAGCTGCGGTCCCGCCCGCCCTTGTACGCCTACAAGCCCGTCCTGCGCCGGGCGATGTGCCGTGTACTGCCGCCCCAGCTCGCTGCCCGCACCACCAAGGGCAGCTTCAACACAGCCCACTACACCGGGATGCGCGCGAACCTGCCGGCGCTGACCGACCTCACCGAGGGCCATCTGGCCGGGCTGGGGATCATCGAGCCGGGTCTGCTCCGCACGCAACTGGCCCGAGGAGCCGCCGGCGTCCCCATGCCACTCGCAGCGATCGAACAGTTCCTCACGACCGAGGCATGGCTGCACTCCCTCCACCGTGCCCCGGCCCTTGTCTGGACCCGGGAGGAAAACGCCCATGTCTGA	MFFGGFTVGCSDGLRPHGTEYADAARSVWSGPMMVRAVSGADGGTVMVLGRCGASEAELGTVAGGQLPEDVTWRWPGTYTVVEHRAEGVVLHTDPAGAMPLYTAEFGGGWAWSSSARVLATLTGAALSAERLAVSVFASYVPAAGARSFFTGVRLLPPGSRVWLPSDGGTPRCTTVWRPDPVPGDPARRFRVVLQAAVEYRTVLDPEVSCDLSGGLDSSTLALLAAAARPAEGHLNGVTVHPDDDTSGADLHYARLAAARDPRIAHHLLSLGTEQLPYTDITAVPATDEPAPSTLARARLEYQLDWMKSEFGTRTHMTGDGGDSVLFVPPAHLADLLRHRRWARAVSEATGWARLRHTAVLPLLNNARRLAGVSRADAFADLAHTVEGAGHPAGEDRGDVTWVPQLPMPPWITEKARSLLAGGLRRAAAEADPLPGLDLGPRVLVDEIRELARTAAADAQLADQQGVELHNPFLDAHVVDAVLRTELRSRPPLYAYKPVLRRAMCRVLPPQLAARTTKGSFNTAHYTGMRANLPALTDLTEGHLAGLGIIEPGLLRTQLARGAAGVPMPLAAIEQFLTTEAWLHSLHRAPALVWTREENAHV	MRHATILNLCGLAASTLFFATTSAFATAAPAERLKALVDAAVQPVMKANDIPGLAVAITLKGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWPALQGSRFDGISLLDLGTYSAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNPSIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVGPGSLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEAYDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRDVGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR	151.64	gnl|BL_ORD_ID|4229|hsp_num:0	5299			207	471	
BGC0001435.1|Ikarugamycin_13 # 19122 # 19328 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGTGG;rbs_spacer=10bp;gc_cont=0.715	BGC0001435.1|Ikarugamycin_13 	19122	19328	-	Loose	530	22.7126	OXA-899	33.33	3005093	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCGCCCCCAGAAACGCAGCGGGACATCAATTGATCCACGGTAGCGAGCCGGCCGCGGCCGGGTCGAGGCCGTATGCGCAGCACGCACGCGGTGTGCACGGCCCGGGAAATCCCTCGGTGGCCGGCCGGGGCGGCGGTGTGATGGGAGGGCAGCACAGACCCCGGGCAACCTGGCCCGAGGCGCACGCGGAAGGAGAACTGTGA	MTAPRNAAGHQLIHGSEPAAAGSRPYAQHARGVHGPGNPSVAGRGGGVMGGQHRPRATWPEAHAEGEL	MMKRRHAATGALLAALATFAHAEHPICTIVADGATGKAVLQEGRCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGFMRRIVNRQLPVSARTYEMVDRTVQTWQVPGGWSVHGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALLARLPEVLAFAGQ	24.73	gnl|BL_ORD_ID|2809|hsp_num:0	3826			498	681	cloxacillin; oxacillin; cefalotin
BGC0001435.1|Ikarugamycin_16 # 20762 # 21331 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0001435.1|Ikarugamycin_16 	20762	21331	-	Loose	300	24.2534	poxtA	34.62	3004470	protein homolog model	n/a	n/a	tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGTGTACCCCGGGGGGTATTCGGATACCCACCCTAACAGGGGTACCCCAGGGGGTATTCCTGTGGTGCTGGCGTCCCCGCATCCCCGGGTGCGGCATTGCGTCCACCCCGCCGGGTACCCGGCGGGGTATCAAGGAGCCGGGTTCTCCGCCTCACCGAAGGAGCAGCGCACCGTGCCCTACGACCGCACCGTCCGCCTGGCCGTCACCGACTTCGACGCCGCCACCACCGCCGTCCGCCAGGCCCTGGCCGACCAGGGGTTCGGCATCCTCACCGAGATCGATGTCCGGGCCACGCTGAAGGCCAAGCTCGGCCACGACATGGAGGACTACCTCATCCTGGGCGCCTGCAACCCGCCGCTCGCCCACCGGGCCCTGGAGGCCGACCGCTCCATCGGACTGCTCCTGCCCTGCAACGTCGTCGTCCGCCGCGACGGCGACCACGTGCTCGTCCAGGCACTCGACCCGGACACCATGGTCACCCTCACCGGCCTGGATTCCCTCAAACCCGTCGCCGACGAGGCCACCGCCCGGCTCGACGCCGCGCTCAGCACCCTGGCCGCCACCTGA	MVYPGGYSDTHPNRGTPGGIPVVLASPHPRVRHCVHPAGYPAGYQGAGFSASPKEQRTVPYDRTVRLAVTDFDAATTAVRQALADQGFGILTEIDVRATLKAKLGHDMEDYLILGACNPPLAHRALEADRSIGLLLPCNVVVRRDGDHVLVQALDPDTMVTLTGLDSLKPVADEATARLDAALSTLAAT	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	34.87	gnl|BL_ORD_ID|2510|hsp_num:0	2904			1005	1083	tetracycline; doxycycline; linezolid; chloramphenicol; florfenicol
BGC0001435.1|Ikarugamycin_17 # 21353 # 22717 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0001435.1|Ikarugamycin_17 	21353	22717	+	Loose	500	44.2838	SPG-1	29.38	3003720	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPG beta-lactamase	GTGTTCTTCGTCGACACCCTTGATTTCGAGGGTCTGGGCAACCGCAGCTACCTGGCCGGCGGGGCCGCCGGCGCGGTGGTCATCGATCCGCCGCGCGACATCGACCAGGTGATCGCCGCCGCCGCCAGACGCGGGGTGACCATCGCGTACGTGGCGGAGACCCACATCCACAACGACTACGTCAGCGGCGGCCTGGAGCTGGCCCGCGTCACCGGCGCCTCCTATCTGGTGCCCGCCGCGGCGCACGTGTCCTTCGCCCGCACCCCGGTCGGCGACGGGGACACCGTGGACGTGGACACGGGACTGGTCCTGCGCGCGATCGCCACGCCCGGACACACCCCGCACCACACCTCCTACGTCCTGGAGCAGGACGGGCGCGGCGTGGCGGCGTTCACCGGCGGATCGCTGCTGATCGGCACGGTGGGCCGCCCCGACCTGGTGGAGCCCCGGCTGACCGAGCGGCTGGCCCGGGCCCAGCACGCCTCCGCCCACCGCCTGGCCGCCGAGCTGCACGACGAGGTGCCGGTGCTGCCCACCCACGGGTTCGGCAGCTTCTGCTCCTCCGCCCAGGCCGAGGGGGACGCGACCACGATCGGCAGGGAACGTGCCAGCAACGACGCGCTCACCCTGGACGTGGAGACCTTCGTTCAGCGGACGCTCGCCGGGCTGGAGGACGTGCCCGCCTACTACGCGCACATGGGCCCGGTCAACGCCGCCGGCCCCGCCCTCCTCGACCTCACCCCGCCCGAGCGTGCGGACGCGGGCGAGATCTCCTCCCGGCTGGCCGCGGGCGAGTGGGTGGTGGACCTGCGCAGCCGCGTGGCCTTCGCCGAGGGGCACGTGGCCGGCTCGTTCAACTTCGAGGGCGAGGGCAAACTCGCCACCTACCTGGCCTGGCTGATCCCGTGGGGCAAGCCCGTCACCCTGCTCGCCGACACCCCGCGGCAGATCGGCGCCGCGCAGCGGGAGCTGGCGCGGGTGGGCATCGACCGCCCGGCCGCCGCCGCCACCGGCGACCCGGCCGGCTGGATCCGGGAGGGCGAGCAGCTCGCCTCCTTCCCGCGTGCCCGCTTCGCCGACCTCGCCCGGGTGCGCGAGCGCGGCGACGAGGTGGCCGTCCTGGACGTGCGCCGGGAATCGGAGCGCGTGGGCGGCTACATCGACGGCTCGGTCCACATCCCGATCCACGAGCTGCACGGCCGTATCGGCGAGGTGCCGGACGGGACGGTGTGGGTGCACTGCGCGGGCGGGATGCGCGCGGCGATCGCCGCCTCCCTGCTCGATGCCGCCGGCCGCGATGTGGTCGCCGTGGACGACGGTTTCGACGCCGCGACGGATGCCGGGCTGCCCCTGACCTCCGCCTGA	MFFVDTLDFEGLGNRSYLAGGAAGAVVIDPPRDIDQVIAAAARRGVTIAYVAETHIHNDYVSGGLELARVTGASYLVPAAAHVSFARTPVGDGDTVDVDTGLVLRAIATPGHTPHHTSYVLEQDGRGVAAFTGGSLLIGTVGRPDLVEPRLTERLARAQHASAHRLAAELHDEVPVLPTHGFGSFCSSAQAEGDATTIGRERASNDALTLDVETFVQRTLAGLEDVPAYYAHMGPVNAAGPALLDLTPPERADAGEISSRLAAGEWVVDLRSRVAFAEGHVAGSFNFEGEGKLATYLAWLIPWGKPVTLLADTPRQIGAAQRELARVGIDRPAAAATGDPAGWIREGEQLASFPRARFADLARVRERGDEVAVLDVRRESERVGGYIDGSVHIPIHELHGRIGEVPDGTVWVHCAGGMRAAIAASLLDAAGRDVVAVDDGFDAATDAGLPLTSA	MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPRGHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVANVADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTTRIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDEKRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR	159.30	gnl|BL_ORD_ID|2032|hsp_num:0	2235			147	624	
BGC0001435.1|Ikarugamycin_18 # 23089 # 23628 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=CCC;rbs_spacer=11bp;gc_cont=0.741	BGC0001435.1|Ikarugamycin_18 	23089	23628	+	Loose	275	26.5646	Streptomyces rimosus otr(A)	35.71	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGGCCTGGAGGACAGGGGCGCTGTTCGCCGCCGCGGGCATCGTCCCCGCTTTCCTCGCCGGCGCTGTCGCCGGACGCCCGCCCGCAGCGGTACTGACGGCGGCGTTCGCGGTCATCGCCGCGCTGGCGGCCCTGCGCATGCTGCGCCCGTCCGCGTCCGAGCCGCCGGACCGGATCCGTCCCGGCAAGGCGGCCGGTGCCGGTGCCGGACTCGGCGCCGTGACAGGCCTGCTGGGGGTCGGCGGGGGATTCCTCGCCGTGCCCGCCCTGGTGAGCGTCCTGGGGCTGGCCATGCGCCGGGCGGTGGGCACCAGCCTGCTCGTCATCACCGTGAACTCACTCGCCGCGCTCGCCGCCCGCAGCGGCACCACCGGCGAACTCCACTGGGAGATCATCGGCCCCTTCACCGGAGCCGCGATCCTCGGCGCCTGGGACGGCAAACGCCTCGCGACGAAGATCTCCGGCACCACCCTGCGGAAGATTTTCGCCGGCCTCCTGCTGGCGGTGGCGGCCTTCATGCTCGTCGACGTGATCGTCTGA	MAWRTGALFAAAGIVPAFLAGAVAGRPPAAVLTAAFAVIAALAALRMLRPSASEPPDRIRPGKAAGAGAGLGAVTGLLGVGGGFLAVPALVSVLGLAMRRAVGTSLLVITVNSLAALAARSGTTGELHWEIIGPFTGAAILGAWDGKRLATKISGTTLRKIFAGLLLAVAAFMLVDVIV	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	27.00	gnl|BL_ORD_ID|4807|hsp_num:0	1273			1776	1932	oxytetracycline
BGC0001435.1|Ikarugamycin_19 # 23766 # 24341 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0001435.1|Ikarugamycin_19 	23766	24341	+	Loose	275	25.0238	AAC(6')-Is	27.27	3002562	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACCACACCCACGGCCCTCGCCACCGACGAGGCGCGCACCCGCCTGCACGAACTGACCATCATCGACGTGCGCACCCCGGGCGAATACGCCGGCGGCCATCTGCCCGGCGCGCTCAACATCCCCCTCGACCAGATACGGCGCGCGCTGCCCGACATCCGTCAGGCCGCCGGCCGCGGCGACATCCTGGTCGTCTGCGCCTCGGGCGCCCGCTCCCAGAACGCCTGCACGATCCTCGCGGAGAACGGCGTGACCGCCGCCACCCTGTCGGGAGGCACCGGGGCCTGGGCGGCCGACGGCCACGAGCTCCACCGCCCCCAGGGCGTCTCCCGTGCCGCCTGGGGAATGGAGCGGCAGGTAAGGCTCACCGCGGGAGTGATCGTGCTGCTCGGCCTGCTGCTCGGGCTCGTCGTGCACCCCGCCTTCCAGTTCCTCTCCGCCGGCATCGCGGGCGGTCTGGTCTTCTCCGCCCTGACCAACACCTGCGGCATGGCCGCCATGCTCGCCAAGCTCCCCCACAACCGCCCCCGCGCCGCCGACCTCGACAACACGCTGGCCGCACTGCGCGACCGCTGA	MTTPTALATDEARTRLHELTIIDVRTPGEYAGGHLPGALNIPLDQIRRALPDIRQAAGRGDILVVCASGARSQNACTILAENGVTAATLSGGTGAWAADGHELHRPQGVSRAAWGMERQVRLTAGVIVLLGLLLGLVVHPAFQFLSAGIAGGLVFSALTNTCGMAAMLAKLPHNRPRAADLDNTLAALRDR	MNIMPISESQLSDWLALRSLLWPDHEDAHLLEMRHVLKQTDTLQLLVYSETQLAIAMLEASIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQCVEEWAKQFACTEFASDAALENTISHAMHRALGFHETERVVYFKKNIG	130.82	gnl|BL_ORD_ID|495|hsp_num:0	544			249	435	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001435.1|Ikarugamycin_20 # 24459 # 24749 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=12bp;gc_cont=0.660	BGC0001435.1|Ikarugamycin_20 	24459	24749	-	Loose	2000	23.0978	oqxB	35.9	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTGGGTTGTGGAACTGGCGATGGCGGCCGAGGAACTGAAGACAGTGGTCAACCGGCTGCGCCGGGCGCAGGGCCAGATCGCCGGGGTGATCAAGATGATCGAGGAGGGGCGGGAGTGCGAGGACGTCGTCACCCAGCTCGCCGCGGCGTCCAGGGCTTTGGACAAAGCCGGTTTCGCGATCATCGCCACGGGGCTGCAGCACTGCCTGACCGACGCGGACATGGCTGCTTCCGGTGACCGGGAGCAGATGCGGGCTCGGCTGGAGAAGCTGTTCCTTTCTCTCGCCTGA	MWVVELAMAAEELKTVVNRLRRAQGQIAGVIKMIEEGRECEDVVTQLAAASRALDKAGFAIIATGLQHCLTDADMAASGDREQMRARLEKLFLSLA	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	9.14	gnl|BL_ORD_ID|2152|hsp_num:0	2400			1260	1377	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0001435.1|Ikarugamycin_21 # 24948 # 25427 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=CCCCC;rbs_spacer=5bp;gc_cont=0.717	BGC0001435.1|Ikarugamycin_21 	24948	25427	+	Loose	340	41.5874	sta	38.16	3004699	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	GTGCGTCTGCACATCGTCACGTCGGATGACTGGCCGCTGTGGCAGGAGGTCCGCGTCGCCGCGCTGACCGATGCGCCGTATGCCTTCAAGGCCCGGCTCGCCGACTGGGACAGGGGCGGCCGGGAGCAGTGGCGTGCTCGTCTGGACCTGCCCGGCTCCCACAACGTCGTCGCGCTGCGCGGAGACCTGCCCGTGGGCATGGTCAGAGGCATCCGCGGTGACCACGGGACGAGCGAGCTCAGGTCGCTGTGGGTCAGCCCCGCGGCACGGGGTGACGGTGTCGGAGACCGGCTGATCGAAGCGGTGACGCACTGGGCGCGGCGGTCGGGCGCCACCACGCTCAGGCTCGCGGTGATCCCGGGAAACGCGTCCGCCCTCGCCCTCTACCGGCGCAACGGGTTCGCCGCCACCGGAGAGTTGGGAGAGCTGTTGCCCGGCGGTGTGACCGGGGAGCAGGTGCTGGCCCGGAGACTTTCCTGA	MRLHIVTSDDWPLWQEVRVAALTDAPYAFKARLADWDRGGREQWRARLDLPGSHNVVALRGDLPVGMVRGIRGDHGTSELRSLWVSPAARGDGVGDRLIEAVTHWARRSGATTLRLAVIPGNASALALYRRNGFAATGELGELLPGGVTGEQVLARRLS	MTTTHGSTYEFRSARPGDAEAIEGLDGSFTTSTVFEVDVTGDGFALREVPADPPLVKVFPDDGGSDGEDGAEGEDADSRTFVAVGADGDLAGFAAVSYSAWNQRLTIEDIEVAPGHRGKGIGRVLMRHAADFARERGAGHLWLEVTNVNAPAIHAYRRMGFAFCGLDSALYQGTASEGEHALYMSMPCP	84.13	gnl|BL_ORD_ID|2220|hsp_num:0	3397			318	546	streptothricin
BGC0001435.1|Ikarugamycin_22 # 25512 # 26795 # -1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=CCCCC;rbs_spacer=9bp;gc_cont=0.706	BGC0001435.1|Ikarugamycin_22 	25512	26795	-	Loose	400	25.7942	kdpE	36.36	3003841	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	GTGCCGGCCGGCACACGCCCTCACCATGTCCCAGCCACGAAAGGCAACACCGCCCCCATGCCCGGACAGCAGGAACAGCAGGCACCGTCGGAGCACCCGGAGCAGCAGGAACTCCTCACCTTCCCCTTCGCCTCGACGGGTCTTGAGTTTCCCCCCGTCTACCACGAGCTGTACCAGCAGCGGCTCACCAAGGTCCGGCTCCCCTACGGCGACGACGCCTATCTCGCCATCCGGTACGCCGATGTGAAGACCGTGCTGTCCGACTCCCGGTTCTCCATCGTCGCCTCCCTCGGCCAGGACCAGCCACGCACCCGGGCCGGGGCCCGCGTCGGCAACGGCCTGTTCTCCCTCGACCCCCCGCAGCACTCCCGGCTGCGCTCCGTCCTGGGCCGGGACTTCACCCCGCGCCGGGTGGAGAAGCTGCGCGAGCGGGTGCGGGAGCTGACCGACCAGTGCCTGGACCGGATGGAGGCCGCCGGGTCCCCCGCCGATCTCGTCGCCCACCTCGCCGTGCCGATGCCCACCGCCGTGGTCTGCGAGATGATGGGCGTGCCCGAGCCCGACCACCACCTGTTCTGGGGCTGGGCCGAGACGATCCTGTCGAACGACACCACGCCCGACGACCTCATCCGGCGCTACCAGGAGTTCACCGCCTACATGGGCGCCATGGTGGAGGAGCGCCGCGCCCGACCCACCGACGACATGTTCGGCATGCTGGTGCGGGCCTGCGACGAGGAGGGCCGGATCACCGAGATCGAGATGCACGCGCTCGCCTCCGACCTGCTCAGCGCCGGCTTCGTCAGCACCGCCCACCAGATCGCCAACTTCACGGCCATGCTGCTGGCCCGCCCCGAAAGGCTCCAGCCCCTGGTGGACAAGCCGGAGCAGATCCCGGCCGCCGTCGAGGAGCTCATGCGCCACGTGCCGATCCTCAGCGGCTTCTCCTTCCCCCGCTACGCCACCGAGGACCTGGAGATGAGCGGGGTGACCGTCCGCCGCGGCGAGGCCGTCATCCCGGTGATCGCCGCCGCCAACCGCGACCCCGACGTCTACCCGGACGCCGGCCGCCTCGACCTCGAACGCAACGGGCTCCCGCACCTGGGCTTCGGCCAGGGCCCGCACTTCTGCATCGGCGCCCATCTGGCCCGGGTCGAGCTGCAGGTGGTCCTCGAAGCCCTCACCGAGCGCTTCCCCGACCTGCGCTTCGGCATCCCCGAGAACGCTCTCAAGTGGAAGCGGGGCCACTTCATGAACGGCCTCCACGAACTGCCCGTCGCCTGGTAG	MPAGTRPHHVPATKGNTAPMPGQQEQQAPSEHPEQQELLTFPFASTGLEFPPVYHELYQQRLTKVRLPYGDDAYLAIRYADVKTVLSDSRFSIVASLGQDQPRTRAGARVGNGLFSLDPPQHSRLRSVLGRDFTPRRVEKLRERVRELTDQCLDRMEAAGSPADLVAHLAVPMPTAVVCEMMGVPEPDHHLFWGWAETILSNDTTPDDLIRRYQEFTAYMGAMVEERRARPTDDMFGMLVRACDEEGRITEIEMHALASDLLSAGFVSTAHQIANFTAMLLARPERLQPLVDKPEQIPAAVEELMRHVPILSGFSFPRYATEDLEMSGVTVRRGEAVIPVIAAANRDPDVYPDAGRLDLERNGLPHLGFGQGPHFCIGAHLARVELQVVLEALTERFPDLRFGIPENALKWKRGHFMNGLHELPVAW	MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML	189.78	gnl|BL_ORD_ID|2103|hsp_num:0	2331			402	534	kanamycin A
BGC0001435.1|Ikarugamycin_23 # 26969 # 28987 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=12bp;gc_cont=0.743	BGC0001435.1|Ikarugamycin_23 	26969	28987	-	Loose	750	27.335	tet(55)	36.73	3004591	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTCGAGGCACACCGACCCGTACGCGGCCGCAGGTCCGGAGGCGGACGGCCCGTTCCTGCGGGTGACGCTCGCCTCCGGGACCACCGTCCGCGTCGAGTGCACCGTTCCGCTGGACGGGGTGTTGCGGCTGCGGCTCGCCGACCGGCCCGCCGCCGTCCACCACCACGACTCGCCGGTGCTGCTGGACGCCCCGCGCCGCCCGGCGCGGCTGCACACCACCCCCGAGGGGGTGGAGATCACCGGGCCCGGGGTGCGGGCGCTGTGGGAACGCGGGCCGGGGCAGGGCTTCCACTTCGGCACCTACCACCGCTTCAGCGAGCCGGAGGCCGGTATCGCGCCGTTCCGCTCCGGGTACCGGCCCGCGAGCCGGCACCACCGCACCGCCTCGTGGGTGGAGACCATCCACCTCAACCCGGGCCACTGCGTCTACGGCGGCGGCGAGAGCTACCAGGGCATCGACCTGCGCGGCCGGCGCCGCACGCTGCGCAACACCGAGGAGAACCGCGCCGCCGGGCGCGACACCGCCTACCTCAATGTGCCGCTGCTGTGGTCGGACGCCGGCTGGGGCCTGTTCGCGCACACCGGCGGGCCCGTCGACGCCGACATCGGCGCCACCCACGCCGAGGCCGCCCGGATCGAGATCGAGGGCGATGACCTCGACCTCTTCCTCATCAGCGGCGACGCCCCCACCATCCTGGACCGCTACCTCACCCTCACCGGCCGTCCGCACCCGCTGCCCGACTGGGCGTTCGGGGTGTGGATGAGCCGCTCCTCCTACTTCACCGCGGACGAGATGGTCCGCACCGTCGACGAACTCCAGGCCGCCGGCTGCCCGGTGGACGTGATGCACGTCGACGAGTGGCTGGCCGGCAGCGTCCTGGAGGCCGCCGCCTGGACGTACGGGCCCGACCGGCGCCGCTTTCCGCGGGACTGGTCCCGGCAACTGGCCCAACGCGGAGTGCGCACCAGCCTGTGGATCAACCCGTACGTCAAACGCGGCACTCCGCTGGGCGACGAGCTGACCCGGCGCGGCTACCTCGTCCGGGACGTGTACGGCGCCCCGGCGCCCACCGCCGACAACCCGGACTCCCTCGTCGTCGACTTCACCCACCCCGAGGCCCGCGAATGGTGGTGCGAGCGGCTGGCCGACGCGCTGCGCGAGGAACACGCGAGCGCCGTGCTCGCCGACTTCGGCGAGGAGATCCCCGCCGACGCGGTCTTCGCCGACGGCAGCCGGGGCACGCAGCGCCGCAACTCCTACGGGCTGATCTACCAGGAGGTGGTGCGCGAGGCGGGACTGCGCGCCCGCGCCGGGGACTTCACGGCGATCGCCCGCTCGGGCACGGCGGGCTCGCAGCGCAACCCGGCGCACTGGGCGGGTGACATGCCCTCCAGCTGGAGCGGACTGGCGTCCACGGTGCGCGCCGTGGAGTCCATGGCGCTCAGCGGCTGCTCGGTGGTCACCCACGACGCGGGCGGCTACTACACGCCCCAGTCCTTCGAAGCCGCCTACGTGGTGCGGCAGCGGATGACACCGGACGCCGTACCCGCGGACGTGGAGCCCGAGTTGTACGGGCGGTGGGCGCAGTGGGCGGCGTTCTCCCCGATCATGCGGTTCCACGGGATGGGGCGCAGGGAGCCGACCGCCTACCCCGAGCCGGTACGGTCGGCCGCCATCGCGGCGTGCCGGCTGCGGCACCGGCTCGCCCCGTACATCGCCGGCTGCGCCGCCGAGGCCACCAGGGAGGGCGGGATGCCCCTCATGCGGCCGATGCCGCTCGCCTTCCCCGAGGACCGGTGCGCCCGCGACGCGCAGTTGCAGTACCTGCTCGGTCCTGACGTGCTGGTGGCCCCGGTGCTGGAGCGGGGCGGGCGCCGCGATCTGTACGTGCCGCCGGGGGAGTGGCGGCAACTGCTGGGCAAGGGCTCCCTGACGGGGCCGGGCTGGCGTGAAGTGCGGTGCGGGCCGCAGGAGTTCCCCGGCTATGTGCGCGCCGGGCGGGAAATAGGACTGTGA	MSRHTDPYAAAGPEADGPFLRVTLASGTTVRVECTVPLDGVLRLRLADRPAAVHHHDSPVLLDAPRRPARLHTTPEGVEITGPGVRALWERGPGQGFHFGTYHRFSEPEAGIAPFRSGYRPASRHHRTASWVETIHLNPGHCVYGGGESYQGIDLRGRRRTLRNTEENRAAGRDTAYLNVPLLWSDAGWGLFAHTGGPVDADIGATHAEAARIEIEGDDLDLFLISGDAPTILDRYLTLTGRPHPLPDWAFGVWMSRSSYFTADEMVRTVDELQAAGCPVDVMHVDEWLAGSVLEAAAWTYGPDRRRFPRDWSRQLAQRGVRTSLWINPYVKRGTPLGDELTRRGYLVRDVYGAPAPTADNPDSLVVDFTHPEAREWWCERLADALREEHASAVLADFGEEIPADAVFADGSRGTQRRNSYGLIYQEVVREAGLRARAGDFTAIARSGTAGSQRNPAHWAGDMPSSWSGLASTVRAVESMALSGCSVVTHDAGGYYTPQSFEAAYVVRQRMTPDAVPADVEPELYGRWAQWAAFSPIMRFHGMGRREPTAYPEPVRSAAIAACRLRHRLAPYIAGCAAEATREGGMPLMRPMPLAFPEDRCARDAQLQYLLGPDVLVAPVLERGGRRDLYVPPGEWRQLLGKGSLTGPGWREVRCGPQEFPGYVRAGREIGL	MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMGIYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIPCFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCYISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKDFLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAEQAEERNNIVLGIMKKATHAIELPEY	174.55	gnl|BL_ORD_ID|2727|hsp_num:0	3293			927	1065	tetracycline; minocycline; oxytetracycline
BGC0001435.1|Ikarugamycin_24 # 29061 # 31478 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0001435.1|Ikarugamycin_24 	29061	31478	+	Loose	300	26.9498	poxtA	32.43	3004470	protein homolog model	n/a	n/a	tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGACACTCACGGTGGAACGGCGCGCCGCCGTCCTGGGCGCGGACGAGCTGGCGGCCCTGGACGCGCGCTGGCGGGCGGCGAACTATCTGACCGCCGGGCAGTTGTACCTGCTGGACAACCCGCTGCTGGCCGAGCCACTGCGGCCCGAGCACATCAAGCCGCGGCTGCTGGGGCACTGGGGTACCGCACCCGGCCTCAACCTGCTGCACGCGCATCTGAACCGGGTGATCGACGCCCGCGCCCTGGACGCCATGTGCGTGTGGGGCCCGGGGCACGGCGGCCCGGCGGTGGTGGCGGGCACCTGGCTGGACGGCACCTGGAGCGAGGTCTACCCGGATGTGCCCCGGGACGGGGCGGGGATGGCGCGGCTCTTCCGCCAGTTCTCCTTCCCCGGCGGGATCCCCAGCCACGTGGCGCCCGACGTCCCCGGCTCGATCAACGAGGGCGGCGAGCTGGGCTACAGCCTGGCGCACGCGTACGGGGCGGCGCTGGACAATCCGGGGCTGCTGGTGGCGTGCGTCATCGGGGACGGCGAGGCGGAGACCGGGCCGCTGGCGGGTTCCTGGCACGCGAACAAGTTCCTGGACCCGGTGCACGACGGGGCGGTGCTGCCGGTGCTGCACCTCAACGGCTGGAAGATCGCCAATCCCACGGTCCTGGCCCGGCTGCCCGAGGAAGAACTGACACAGTTGCTGCGCGGGTACGGCCACGACCCGCTGTTCGTCTCCGGCGACCGGCCCGAACTCGTCCACCGGGAGCTGGCCGGGGCGCTGGACGAGGCGGTGGAACGGATCGGCCGGCTCCAGCGCGCGGCACGCGGCGGGGCGGCCGGGGGCGTACGCGAGCGTCCCCGGTGGCCGCTGATCGTGCTGCGCACGCCGAAGGGCTGGACCGGGCCGGACGAGGTGGACGGGCTGCCGGTGGCCGGCACCTGGCGCTCCCACCAGGTGCCGCTGGACGGGGTGCGCGAGAACCCGCGTCACCTGCGGCAGCTGGAGACCTGGCTGCGCTCGTACCGCCCCGAGGAGCTCTTCGACGAGCGGGGCCGGCCGCGTGAGGCGGTGCTGGCGCAGGTGCCGCACGGCACGCGGCGGCTGGGCAGTACGCCGCACGCCAACGGCGGGCTGCTGCTGCGGGACCTGCCGGTGCCGCCGCTGGAGGGCGCGGCGGTGCCGGTGGAGCGGCCCGGCAGCACGCTGCACGAGCCGACCCAGGTGCTGGGCACCCTGCTCACCGAGCTGATGCGGGCCACCGCGGCGCGGCGCGACTTCCGCATCGTGGGCCCGGACGAGACGGCCTCCAACCGCCTGGACGCGGTGTACGAGGCCACCGGCAAGGAGTGGGAGAGCGCGGTGCTGGGCGTGGACCGGCATCTGGAGCACGGCGGCCGGGTGATGGAGGTGCTCTCGGAGCATCTGTGCCAGGGCTGGCTGGAGGGCTATCTGCTCACCGGGCGGCACGGCCTGTTCTCCTGCTACGAGGCGTTCGTGCACATCGTCGACTCGATGGCCAACCAGCACATCAAGTGGCTGCGCTCCGCGCGGCGGCTGCCGTGGCGGGTGCCGATCGCCTCCCTGAACTACCTGCTGACCTCCCACGTGTGGCGGCAGGACCACAACGGCTTCTCGCACCAGGACCCGGGCTTCGTCGACCATGTGCTGAACAAGAGCCCGGAGGTGGTGCGGGTCTATCTGCCGCCGGACGCCAACACGCTGCTGGCGTGCGCCGATCACGTGCTGCACAGCCGGGACTACGTGAACGTGGTGGTGGCCGGGAAGCAGCCGTGCTTCGACTGGCTGGACCTGGAGAGCGCGCGGGCGCACTGCGCGCGCGGCGCCGGGATCTGGGAGTGGGCCGGTACGGAGTCGGCGGGTTCCGGGCGCGAGCCGGACGTGGTGCTGGCCTGTGCCGGGGACGTCCCCACGCAGGAGACGCTGGCGGCGGCGTGGCTGCTGCGCCGGGAGCTGCCGGGGCTTTCGGTGCGGGTGGTCAACGTGGTGGACATCGCGCGGCTGCTGCCCGCCGAGGAGCATCCGCACGGGATGGCGGACGGCGAGTACGACGCGCTGTTCACCCGCGACCGGCCGGTGATCTTCGCGTACCACGGCTATCCGTGGCTGATCCACCGGCTGACGTACCGGCGGGCCGGGCACGACCAGCTGCATGTGCGCGGCTACCGCGAGCAGGGCACGACCACGACGCCGTTCGACATGGTGGTGCGCAACGATCTGGACCGCTACCGGCTGGTGATGGATGTGATCGACCGGGTGCCGGGGCTCGCGGTGCGGGCGGCGGGCGTACGGCAGCGGATGGCGGATGTGCGGTTCCGGCACGAGCGGTGGATCCGGGAGCACGGCGACGATCTGCCGGAGGTGGCCGGCTGGCGGTGGGACGACGGCGAGGGCGGCGGATCGTGA	MTLTVERRAAVLGADELAALDARWRAANYLTAGQLYLLDNPLLAEPLRPEHIKPRLLGHWGTAPGLNLLHAHLNRVIDARALDAMCVWGPGHGGPAVVAGTWLDGTWSEVYPDVPRDGAGMARLFRQFSFPGGIPSHVAPDVPGSINEGGELGYSLAHAYGAALDNPGLLVACVIGDGEAETGPLAGSWHANKFLDPVHDGAVLPVLHLNGWKIANPTVLARLPEEELTQLLRGYGHDPLFVSGDRPELVHRELAGALDEAVERIGRLQRAARGGAAGGVRERPRWPLIVLRTPKGWTGPDEVDGLPVAGTWRSHQVPLDGVRENPRHLRQLETWLRSYRPEELFDERGRPREAVLAQVPHGTRRLGSTPHANGGLLLRDLPVPPLEGAAVPVERPGSTLHEPTQVLGTLLTELMRATAARRDFRIVGPDETASNRLDAVYEATGKEWESAVLGVDRHLEHGGRVMEVLSEHLCQGWLEGYLLTGRHGLFSCYEAFVHIVDSMANQHIKWLRSARRLPWRVPIASLNYLLTSHVWRQDHNGFSHQDPGFVDHVLNKSPEVVRVYLPPDANTLLACADHVLHSRDYVNVVVAGKQPCFDWLDLESARAHCARGAGIWEWAGTESAGSGREPDVVLACAGDVPTQETLAAAWLLRRELPGLSVRVVNVVDIARLLPAEEHPHGMADGEYDALFTRDRPVIFAYHGYPWLIHRLTYRRAGHDQLHVRGYREQGTTTTPFDMVVRNDLDRYRLVMDVIDRVPGLAVRAAGVRQRMADVRFRHERWIREHGDDLPEVAGWRWDDGEGGGS	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	148.52	gnl|BL_ORD_ID|2510|hsp_num:0	2904			1002	1113	tetracycline; doxycycline; linezolid; chloramphenicol; florfenicol
BGC0001435.1|Ikarugamycin_25 # 31491 # 32534 # -1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0001435.1|Ikarugamycin_25 	31491	32534	-	Loose	750	25.7942	tet(53)	36.11	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGCCCGGCGTCCCGGCCGGCGGCCCCGGCATCACACCTGAACTGCTGTTCCAGCGCGATCCGTTGGAAGAATCGTGCGGCGCCTCGGCATACTCCCGGAAGCACTGCGGCGCGGATTGCGTACCGCGACCGCGGTGCCCGCCCGGCACATACCGAGGAGGCCGCATGGTCCGCACCATCGAATCCGCGTCACCCGCGTTGTGCCGACTGCACCTGAGCACCGAACTGCGCCGGCTGCGCGAGGAGTCCCGCCTCACCGCCGGCGAGGTCGCCCGCCGCTTCCACTGGGCCGCCTCCAAGATGACCCGCCTGGAGACCGGCAGCGACGGCGTCGTCAAGCCGTCCGACGTCATGCTGCTGTGCCGTCTGTACGAGGCCGACGCCGAGACCGCCGCCCGCCTGGAGAGCTACGCCGTGGTCACCAAGACCAAGAAGGACTGGTGGCAGTCGCCCGAGTACCGCTCGGTCATCTCACCGGGCTTCCAGGCGTACCTGGCGCTGGAGGCCAGCGCCGCCCAGCTGCACAGCTACCAGTCCGAGTACGTGCCGGGGCTGCTGCAGACGGAGGAGTACAGCCGCGCCGTCCACCGGCTGGGCCCCGCCGACCTCTCCGCCGACCAGGTCGAGCGCCTCACCGCCGTGCGCATGACGCGCAGCGAGGTGCTGTGCCGCGAGGGCGCCCCCAAGCTCACCGCCATCCTCAACGAGGCGGTGCTGCGGCGTACGGTCGGCGGGCGTGAGGTGATGCGCGCCCAGCTCGACCACATCGCCTCGCTGGCCGCCGGGCAGCCGCACATCCGGGTGCTCGTCGTCCCGTTCAGCGCGGGCGCGCACGCCGGGATGAGCGGCCCGTTCGTGGTGATCCGCTTCCGCCAGCCGGGCATGCGGCCCATCGTCTACCTGGAGAACCTGGCCGGCTCCGGCATCACCCGCCGCCCCGACGACGTGGAGAAGTACGGGGACGCCTTCAGCGACCTGCTCTCCAGCGCCCTCGACCAGCAGCAGTCGCTCCGGCTGATCAAGGAGGCGGGCAACGTCCTGTGA	MPGVPAGGPGITPELLFQRDPLEESCGASAYSRKHCGADCVPRPRCPPGTYRGGRMVRTIESASPALCRLHLSTELRRLREESRLTAGEVARRFHWAASKMTRLETGSDGVVKPSDVMLLCRLYEADAETAARLESYAVVTKTKKDWWQSPEYRSVISPGFQAYLALEASAAQLHSYQSEYVPGLLQTEEYSRAVHRLGPADLSADQVERLTAVRMTRSEVLCREGAPKLTAILNEAVLRRTVGGREVMRAQLDHIASLAAGQPHIRVLVVPFSAGAHAGMSGPFVVIRFRQPGMRPIVYLENLAGSGITRRPDDVEKYGDAFSDLLSSALDQQQSLRLIKEAGNVL	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	89.66	gnl|BL_ORD_ID|2724|hsp_num:0	3290			687	792	tetracycline; minocycline; oxytetracycline
BGC0001435.1|Ikarugamycin_26 # 32494 # 33057 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0001435.1|Ikarugamycin_26 	32494	33057	-	Loose	800	26.5646	efmA	29.27	3003954	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCTGTCATGGAGGGAGCACCGGCCCACAGCAGGAGGGAAACCCCGCGCGAGCGCGACGACCGCAACTTCGCCGAACTGCTCCAGGAGCTGCGGGTCACCCAGACAGGCGTGCAGATCCTCTTCGCCTTCCTGCTCACCCTCGCCTTCACCGCCCGCTTCCCGGTGCTCGACGCCTTCCAGCGGGGCACCTACCTGACCACGCTGCTGCTGGCGATGGCCGCGAGCATCCTGTTCACCGCCCCCGCCGCGCTGCACCGGGCGCTGTTCCGGCGCGGCGCCAAGCGGCGCATCGTCGAGGTCTCCTCCCGCCTGGCCGCGCTCGGCCTGGTGACGCTCGCCCTCGCCCTGACCGGTGCGCTGCTGCTGGTGGTGGACGTGGTGGTCTCCCGAACGGCCGGGGTGATCGCCGCGGCCGGTGCCTTCGCCGCGTGCGCCGGGCTGTGGCTGCTGCTGCCCGCCGTGCTCGCCCGGCGGCTGCCGCCGCGCATCCACCGCCGCCGAATGCGCGGCACGGAATTCCGTGCCCGGCGTCCCGGCCGGCGGCCCCGGCATCACACCTGA	MAVMEGAPAHSRRETPRERDDRNFAELLQELRVTQTGVQILFAFLLTLAFTARFPVLDAFQRGTYLTTLLLAMAASILFTAPAALHRALFRRGAKRRIVEVSSRLAALGLVTLALALTGALLLVVDVVVSRTAGVIAAAGAFAACAGLWLLLPAVLARRLPPRIHRRRMRGTEFRARRPGRRPRHHT	MENEQSVVLTNWKRNYLFFLSGQFLSGITSMVVQYAIIWYLTRETGSATILSFATLLGMIPMVLLSPFVGPLVDRWDKKALLIVTDIIVAIFALILAVVGTISESFPIWLVFVSLFMRSVAQTFQMPTIQSIMPTIVPSSHITRTNGQLGMVQSANFIIAPALGAALFSVVPVNYLILLDVLGAVFGVGLLIFVKIPKVSPEILEVPLTIFKDAKFGLQQLMDNKGLWYITINGAFVMLLFMPAISLYPLMTLDYFGGSVGQAGAVEVVYAVGMLLGGALISFIGTWKDRMKPIIIAYIIMGLTIGASGLVPNDSQGFLYFLILNAGAGCATPYFNTLLMAMIQQSYESNVLGRVLGNFNSLMNLAGPIGLLFAGPLADRLGVEKMFLFSGIGILLCGIVLFLTSAARNYDKELQKKLVKEHHEQKDE	43.69	gnl|BL_ORD_ID|2187|hsp_num:0	2426			237	360	erythromycin
BGC0001435.1|Ikarugamycin_27 # 33153 # 34250 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.778	BGC0001435.1|Ikarugamycin_27 	33153	34250	+	Loose	400	27.335	Agrobacterium fabrum chloramphenicol acetyltransferase	31.82	3004451	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGTTCCTGGGGCGCGCGGTCGTCGCCGAGGGCCTGCGGCGGGGTGGGAGGTCACCACCTTCAACCGGGGCCTGTCCGGGGCCGACGTCCCCGGCGTGCGGCCGGTGCGCGGGGACCGCGGGCGGGTCGCCGATCTGCGGCGGCTGGCGAGTGAGGGGCCCTGGGACGCGGTGATCGACAGCTCGGCCGCCGACCTCGGCCCGGCGGCGGTCGCGGCGGGCGCCGAGGCGCTGGAGCCGGTGGCCGCACGGTATGTGTTCGTCTCCTCCGTCAACGCCTACCGGGGCTGGCCGGCCGAGCCGCTCACCGAGTCCAGCGAGCTTTTCGCACCCGCCGGGACGGGGTACGGGCCGCGCAAGGCCGCCGCCGAGCGGGCGGTGGGCGACCGGTTCGGCACCGGGCGCACCGCGGTGCTGCGGCCCGGCGTGATCCTGGGCCCCGGCGAGTACGTGGGCCGGCTGCCGTGGTGGCTGCACCGGGCGCACCGGGGCGGGCCGATGCTGGCGCCCGGCAGCCCCGGGCGGACCATCCAGCCGGTGGACGTACGGGATGTCGCCGCCTTCGCCCTGCGGCTCGCGGGCGCCGCGGGCCCGGTCGGCGGGGCGTACAACGTGGTGGCGCCGATCGGGCGGGAGACGATGGGCGGGCTGCTGCACGACTGTGTGACGGTCACCGGGCGGCGGGCCGAACCGCGCTGGGTGGCGAGCGAGGTGCTGCTGGCGCACGGGGTGCGGCCGTGGACCGAACTGCCGCTGTGGCGGGCGATCGACGGCGGCTGGGAGGTGGCATCGGACGCGGCGCAGGCGGCCGGGCTGATGTGCAGGCCGCTGGCGGAGACCGTGATGGACACCTGGGCCTGGCTGAACGGCGGCGGTCTTCCGGTGGACCATCCGCGCCGGGCCCAGCACGGGATCGACCCGGCCAAGGAGGCGGCGATCCTGGCCTCGCCGGGCGGGCCGGCTGACGGAGCGCCCCGCCCGCCCGGGCCCAAAGCCCGCGCGCCGCACCGCCCCTTCGCGTGTTTCTCCCCGCACCGGGCCCGCCGATGCAACCTTTTTGGCGGGCGCTCCGTGGTGGGGGGTGAAAGGGGGGCCTGA	MVPGARGRRRGPAAGWEVTTFNRGLSGADVPGVRPVRGDRGRVADLRRLASEGPWDAVIDSSAADLGPAAVAAGAEALEPVAARYVFVSSVNAYRGWPAEPLTESSELFAPAGTGYGPRKAAAERAVGDRFGTGRTAVLRPGVILGPGEYVGRLPWWLHRAHRGGPMLAPGSPGRTIQPVDVRDVAAFALRLAGAAGPVGGAYNVVAPIGRETMGGLLHDCVTVTGRRAEPRWVASEVLLAHGVRPWTELPLWRAIDGGWEVASDAAQAAGLMCRPLAETVMDTWAWLNGGGLPVDHPRRAQHGIDPAKEAAILASPGGPADGAPRPPGPKARAPHRPFACFSPHRARRCNLFGGRSVVGGERGA	MENYFESPFRGITLDKQVKSPNLVVGKYSYYSGYYHGHSFEDCARYLLPDEGADRLVIGSFCSIGSGAAFIMAGNQGHRNEWISTFPFFFMPEVPEFENAANGYLPAGDTVIGNDVWIGSEAIIMPGITVGDGAVIGTRALVTKDVEPYAIVGGNPAKTIRKRFDDDSIALLLEMKWWGWPAERLKAAMPLMTSGNVAALYRFWRSDSL	174.64	gnl|BL_ORD_ID|2500|hsp_num:0	2890			288	411	chloramphenicol
BGC0001435.1|Ikarugamycin_28 # 34251 # 34805 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0001435.1|Ikarugamycin_28 	34251	34805	+	Loose	575	24.6386	CblA-1	31.25	3002999	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CblA beta-lactamase	ATGCGCCGCCACGAAGAACAGCACTTCCGGGACTTCGCAGCACAGGAGGCCGCCGCACTGCGCCGCACCGCCTACCTGCTGTGCGGGGACTGGCATCTGGCGGAGGATCTGATGCAGAGCGTACTGATCAAGGTGTACCGGCACTGGTCGCGGCTGGAGCGGCGCGACGCGTTGCAGCCCTTCGTCCGGCGGGTGCTGCTGCGCACCTGGCTGGACGAGAAGCGCAAGCCCTGGCGCCGGGCCGAGCAGAGCTTCGCCACCCTGCCCGAGGTCATCGACCCGGCAGCGGGCCCCGATCAGGCCGCCGACCGGCTGCACACCCGGGCCGTGGTGCGGCACGCGCTGCTCCAGCTGCCGCCGGGGCAGCGGGCCGCCCTGGTGCTGCGGTTCTTCGACGATCTGTCGGTCTCCGACACGGCCGCCGCGATGCGCTGTTCGGAGGGCAACGTCAAGAGCCAGACGGCACGCGGTCTCTCGACGCTGCGCCGGCATCTGGGCCTGAACCGCAACCCGCAGCCGGCCGGCGGCGTGTGGCAGCACGGGTGGGCGTCATGA	MRRHEEQHFRDFAAQEAAALRRTAYLLCGDWHLAEDLMQSVLIKVYRHWSRLERRDALQPFVRRVLLRTWLDEKRKPWRRAEQSFATLPEVIDPAAGPDQAADRLHTRAVVRHALLQLPPGQRAALVLRFFDDLSVSDTAAAMRCSEGNVKSQTARGLSTLRRHLGLNRNPQPAGGVWQHGWAS	MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR	62.16	gnl|BL_ORD_ID|0|hsp_num:0	2			492	702	cephaloridine
BGC0001435.1|Ikarugamycin_31 # 36559 # 36759 # -1 # ID=1_31;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.682	BGC0001435.1|Ikarugamycin_31 	36559	36759	-	Loose	1050	24.6386	srmB	46.15	3002828	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GCGCTGGGCATGACGGTGGACTTCGGCCGGGGCGAGGAGACGCGTACGGAGATCTCCACCAAGTTCCGCCGGGCCACCCTCACCGAAGAACTGACGGCGGCGGGTCTCGCGGTGGACCACTGGTGGACCGATCCGCAGGAACGGTTCGCGATGCTGCTGGTCACTTCCCCGGGTTCGGCCACGGGTTCGGACGGCAGCTGA	ALGMTVDFGRGEETRTEISTKFRRATLTEELTAAGLAVDHWWTDPQERFAMLLVTSPGSATGSDGS	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	12.00	gnl|BL_ORD_ID|110|hsp_num:0	128			1074	1182	spiramycin
